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Katherine Isabella Mackay 
 
The large amounts of data generated by modern proteomics experiments necessitates the 
use of software pipelines to conduct the bulk of the post-processing.  While many software 
packages (both commercial and open-source) are available to perform some or all of the 
necessary post-processing steps, it is usual for each research group to use only the 
instrumentation and software packages with which they are most familiar and/or which are 
available to analyse their unknown data. 
 
The intention of the studies presented within this thesis was to assess the correlation 
between the experimental results obtained when; 
- a single result dataset is obtained and post-processed in parallel using four separate 
software pipelines 
- a single sample is analysed on two different mass spectrometers and post-processed 
in parallel 
and; 
- when different identification thresholds are applied to a dataset prior to parallel 
quantitation of the resultant data sets 
 
Correlation between different mass spectrometry instruments was assessed and found to 
yield high r values, especially at the protein level, and was also found to improve following 
the application of abundance thresholds, however the result of applying score thresholds 
was unpredictable. 
 
The use of manual FDR thresholds prior to importing data into Progenesis LC-MS yielded 
interesting results, which suggest that a threshold of 1% peptide FDR and 1 or 2% protein 
FDR is most effective in terms of yielding accurate ratios while maintaining acceptable 
sensitivity. 
 
 
   
In addition, a consensus method is suggested to utilise the results from multiple software 
pipelines in order to increase sensitivity and reduce the FDR, through the use of the QPROT 
tool[1, 2] and manual post-processing. 
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1 – Introduction 
 
1.1 – Aims and Objectives 
 
The studies described in this thesis aim to explore the assumptions of reliability and 
comparability applied to label-free proteomics data, and to suggest possible strategies of 
evaluating and improving on the accuracy of these assumptions.  While there is much 
innovation in the development of new experimental and post processing techniques, there 
are few published studies investigating these validation questions.  Investigations of this 
nature are however highly relevant to the field of proteomics and the wider field of 
molecular biology, especially as both the popularity of label-free proteomic methods and 
the complexity of those biological systems they are applied to increases. 
 
In the process of the studies presented here, as well as investigating the correlation of results 
obtained using different post-processing methods on the same data (Chapter Two, page 36), 
and using  different instrument platforms with analogous post processing (Chapter Three, 
page 70), it was also intended to identify and implement relatively simple and practical 
strategies that increase the confidence of protein identifications, and hence quantitative 
values, through the use of multiple post processing pipelines (Chapter Two, page 36) in a 
manner analogous to the improvement observed when using multiple search engines to add 
confidence to protein identifications by reducing the false discovery rate (FDR)[3]. 
 
Throughout the remainder of this introduction I will present the experimental basis of 
proteomics and MS, the computation techniques available for the identification and 
quantification of proteins, and the software and instrumentation available. 
 
1.2 – Proteomics  
 
Proteomics is the study of the proteome, which can be defined as ‘the entire protein 
compliment in a given cell, tissue or organism’[11].  At its simplest proteomics describes an 
attempt to catalogue all the proteins present in, for example, cells from certain tissues such 
as muscle or foreskin, or to identify all the proteins expressed by unicellular organisms.  This 
type of identification proteomics has become widely used[12-14], however the questions 
Katherine I Mackay 
  2 
now asked by proteomics are much more complex than simple identification (such as asking 
which proteins are differentially expressed between healthy and diseased cells, or which 
proteins are modified in given cellular conditions – e.g. following infection of cells with a 
parasite).  Also, it is now often desired to obtain quantitative information from most 
proteomic experiments.  The increased availability of complex instrumentation for use in 
proteomics workflows for additional information on the instrumentation available) has led 
to more research groups using proteomics techniques in their studies, and therefore an 
increased demand for bioinformatics software to process the resultant data[15]. 
 
One of the important issues encountered when asking these more complex biological 
questions is that the abundance of any given protein within the cell is constantly changing 
and thus any single experiment will provide only a ‘snapshot’ of the proteins present within 
that cell at the time of sample collection.  While this information is eminently useful for the 
identification of those proteins present in a given condition, it is necessary to study how 
protein expression is changing over time in order to obtain a full understanding of the 
function of proteins within cells and tissues.  While time course experiments have been 
conducted to assess the turnover of proteins within cells[16], this type of study remains 
expensive and challenging and therefore has not become routine. 
 
It is possible to split the methods used to conduct quantitative proteomic experiments by 
two main criteria; whether they use labelled or label-free biological samples, and whether 
they yield relative or absolute quantitation data[15].  Relative quantitation aims to study the 
abundance of proteins in a sample with respect to each other, or to observe fold changes 
across different experimental conditions, while absolute quantitation aims to determine the 
true abundance of the studied proteins in the sample. Both relative and absolute 
quantitation can be achieved using labelled[17] or label-free methods, achieving relative 
quantitation stand alone or absolute quantitation using internal standard[18] based 
strategies. 
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1.3 – Proteins 
 
Proteins are biological macromolecules possessed of a multidimensional structure as a 
function of the chemical composition of their constituent polypeptide regions.  Each of these 
polypeptide regions comprises a polymeric chain of amino acids joined by amide bonds, with 
terminal carboxylic acid and amine moieties, which are joined via amide bonds to form the 
peptide backbone.  A generalised summary of peptide properties and moieties is shown in 
Figure 1. 
 
amide bond
carboxylic acid moiety
amine moiety
 
Figure 1: Summary of generic peptide properties. 
 
There are 20 main amino acids that combine in various combinations to create proteins, as 
shown in Table 1.  The order of amino acids in the polypeptide chains, and hence in the final 
protein chain, is denoted as the primary structure of the protein.  The functionality (i.e. the 
side chains present on the peptide backbone) of each amino acid in the chain contributes to 
the conformation of the protein chain in space via multiple interactions such as Vann der 
Waals forces and hydrogen bonding.  Hydrogen bonding in particular can lead to a very 
ordered sub-structure in suitable polypeptide regions of the protein chain, with this structure 
most commonly taking the form of an α–helix or β–sheet (the properties of each of these 
types of structure are shown in Table 2).  This level of order is denoted as the secondary 
structure of the protein.  Both the α–helix and the β–sheet maximise the pairing of available 
lone pairs of electrons within hydrogen bonds while minimising steric hindrance between 
the polypeptide chains.  A further layer of organisation, denoted the tertiary structure, refers 
to the way in which the different polypeptide regions are folded in space.  This folding is 
caused mainly by hydrogen bonding, disulphide bonding or hydrophobic interactions, and is 
solvent and temperature dependent i.e. the structure may breakdown (or denature) when 
the protein is heated or dissolved in a new solvent for example.  The specific folding of the 
polypeptide chain allows the protein to become biologically active in specific conditions e.g. 
within the cell, in order to perform its function within the body[23]. 
n 
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                                 Name 
              Full                           1-letter code 
Chemical Formula 
(Neutral Molecule) 
 
Monoisotopic Mass 
Alanine A C3H7NO2 71.0372 
Arginine R C6H14N4O2 156.1011 
Asparagine N C4H8N2O3 114.0429 
Aspartic Acid D C4H8NO4 115.0269 
Cysteine C C3H7NO2S 103.0092 
Glutamic Acid E C5H9NO4 129.0426 
Glutamine Q C5H10N2O3 128.0586 
Glycine G C2H5NO2 57.0215 
Histidine H C6H9N3O2 137.0589 
Isoleucine I C6H13NO2 113.0841 
Leucine L C6H13NO2 113.0841 
Lysine K C6H14N2O2 128.0949 
Methionine M C5H11NO2S 131.0405 
Phenylalanine F C9H11NO2 147.0684 
Proline P C5H9NO2 97.0528 
Serine S C3H7NO3 87.0320 
Threonine T C4H9NO3 101.0477 
Tryptophan W C11H12N2O2 186.0793 
Tyrosine Y C9H11NO3 163.0633 
Valine V C5H11NO2 99.0684 
Table 1: Table of the standard amino acids showing molecular formulae and monoisotopic mass[24]. 
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Secondary Structure Conformation Conducive amino acids 
α–helix Polypeptide chains in a right 
handed helix (3.6aa/turn, 
length 0.56nm) 
Alanine, methionine, 
leucine, glutamate 
β–sheet Sheet of polypeptide chains 
of 5-10aa, extended and 
aligned for hydrogen 
bonding between NH and 
C=O groups on adjacent 
chains 
Tyrosine, tryptophan, 
phenylalanine, valine, 
threonine 
Table 2: Summary of α–helix/β–sheet properties and the amino acids most likely to adopt each structure. 
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1.4 - Mass Spectrometry 
 
Mass spectrometry essentially involves the measurement of the mass to charge (m/z) ratio 
of ions within a vacuum.  With the exception of time-of-flight instruments and magnetic 
sector instruments (which are now rarely used), this is achieved via the application of RF and 
dc voltages to create an electric field in which there is a stable path for only those ions of a 
specific mass and charge.  The mass spectrometry instrument scans sequentially through 
each mass in a user specified mass range (e.g. 300-3000amu) to identify those analyte ions 
which are present in the sample. 
 
The original mass spectrometry instruments merely ionised the sample and ‘weighed’ the 
ions produced, however it is now more usual to see ‘hybrid instruments’ which involve a 
fragmentation stage and thus provide more information about the sub-structure of the ions 
of interest through the study of (fragment) daughter ions.  Though there are several methods 
of ionisation and mass analysis, the general schematic of the hybrid mass spectrometer 
remains the same, and is shown Figure 2. 
 
ionisation
source
atmospheric
   pressure
Vacuum Stages
Fragmentation
       stage
2nd mass analyser1st mass analyser Dectector
Figure 2: General schematic of the hybrid mass spectrometer. 
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1.4.1 - Ionisation source:- The ionisation source of choice for the quantitative study of 
proteins is the nano-electrospray source[25], based upon the standard electrospray source 
but able to deal with the smaller sample volumes available.  Electrospray (ESI) is referred to 
as a ‘soft’ ionisation method, with ionisation occurring directly from the sample solution at 
atmospheric pressure.  The ions are then passed through a transition section de-pressurised 
by a roughing pump and from there into the high vacuum stages which contain the mass 
analyser and detector.  ‘Soft ionisation’ refers to any ionisation method which produces 
primarily [M+H]+ ions with minimal fragmentation; this is especially useful when studying 
unknown analytes as it prevents confusion between parent and daughter ions at the full scan 
stage (“full scan” refers to a scan which records all ions present with a m/z ratio within the 
user specified scan range).  Manufacturers provide many subtle variations on the basic 
electrospray ionisation source, however the general principles of operation remain the same.  
Within the ionisation source the sample solution (a polar solvent in which the sample is 
soluble) is nebulised from a capillary tube into the source housing via a needle which is held 
at high potential.  The potential difference between the needle and a counter electrode 
causes charge separation within the liquid and subsequent deformation of the meniscus at 
the needle end to form a cone (the ‘Taylor cone’)[26, 27] as shown in Figure 3.  At the apex 
of this cone the charge density is very high and a fine jet of charged liquid is ejected towards 
the counter electrode.  This jet cannot remain stable and breaks up further into charged 
droplets, which are driven apart by Coulombic repulsion to produce a mist of smaller charged 
droplets containing the ions which were pre-formed in the polar sample solution. 
 
 
Figure 3:  Taylor cone formation at the end of the ESI capillary, and the disintegration of the resulting jet to a mist 
of small charged droplets[26]. 
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Excess charge density moves to the surface of these droplets as a conducting medium, with 
the surface charge density increasing as solvent ions are evaporated to give progressively 
smaller droplets[28].  At some point the surface charge density has increased such that the 
repulsive Coulombic forces between analyte ions become stronger than the force of the 
surface tension which binds the droplet together (this point is known as the Rayleigh stability 
limit).  When this point is reached it causes the droplet to ‘explode’ in a process called 
Coulombic Fission, which occurs multiple times to produce steadily smaller droplets.  Some 
theories suggested that this Coulombic Fission simply continues until repulsive forces cause 
the droplet to break up, giving both free and cluster (adduct) ions in the form of charged 
‘droplets’ which inherit the charge of the parent droplet (the Charged-Residue model).  More 
recent studies have suggested that the droplets do not in fact ‘explode’, but instead eject 
smaller droplets in a process known as ‘droplet jet fission’[29].  This occurs from the 
elongated end of the microdroplets that are deformed by their flight under the influence of 
the electric field.  The charge density is significantly increased in this area of elongation and 
a jet of smaller daughter droplets is produced in a process analogous to the formation of the 
original jet emitted from the Taylor cone at the mouth of the capillary.  The daughter droplets 
formed account for approximately 1-2% of the mass, but 10-18% of the charge of the parent 
droplet, and are therefore subject to an increased surface charge density[26]. 
 
It has also been suggested, by J. Iribarne et al, that when a certain radius is reached, ion 
evaporation becomes favourable over Coulombic Fission and free analyte ions are 
evaporated from the surface of the droplets – their study calculated this point to equate to 
a surface charge density of approximately 108Vcm-3 (this is termed the Ion Evaporation 
model)[30].  Though there is a continuing debate on the exact method of formation of ions 
in ESI, it is generally assumed that the CRM is more appropriate for large molecules and the 
IEM for small molecules, though in actuality the method of formation is likely to be a hybrid 
of these two models. 
 
For efficient analysis, it is necessary for the charge on the droplet to be the same as that on 
the analyte ions to allow those ions to move more easily to the surface of the droplet from 
whence they can evaporate/undergo fission.  As peptide molecules are readily protonated, 
it is usual to conduct mass spectrometry for proteomics in positive ion mode (positive charge 
on source needle, negative charge on the counter electrode to draw positive ions into the 
vacuum stages).  As the ESI source requires a constant stream of liquid it is usual to couple 
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the mass spectrometer to liquid chromatography (LC), with the added advantage of 
increased sample separation and purification of the individual components of the sample 
into separate chromatographic peaks.  Thus in addition to ionization mode, the choice of 
solvent used in the LC stage should also be carefully considered in terms of ionisation 
suitability, as well as chromatographic efficiency, as the more ‘hydrophobic’ an analyte is in 
a given solvent, the easier it will be to overcome the solvation energy and the ions will be 
more easily desorbed into the gas phase[28, 31, 32].  However this must be traded with the 
ability of analyte molecules to form ions or at least strong dipoles in the solvent solution, 
which enhances ion abundance[29].  Taking both considerations into account, it can be seen 
that choosing the correct solvent can therefore have a significant effect on the efficiency of 
ionisation, and the ideal parameters will vary greatly for different analytes.  Therefore all 
solvent characteristics should be optimised for specific analytes – including the pH of the 
chromatographic mobile phases (as positive ions are most readily formed in acidic solutions 
and vice versa). 
 
Once desorbed within the electrospray source, the free analyte ions (and any analyte adduct 
ions) are drawn into the mass spectrometer via the ion sweep cone and passed into the 1st 
mass analyser. 
 
1.4.2 - MS analysis (1st mass analyser):- The 1st mass analyser conducts full scan MS analysis, 
recording the analyte ions according to their m/z ratio.  In almost all hybrid instruments this 
first stage will involve a quadrupole mass analyser. 
 
 
Figure 4: Stable ion trajectories within the quadrupole mass analyser. 
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The four rods in the quadrupole are divided electrically into two pairs, with the voltages 
applied to each rod pair being equal in amplitude but opposite in sign.  The quadrupoles 
repeatedly ‘scan’ through the specified mass spectrum (e.g. 300-3000 atomic mass units) by 
altering the RF and dc voltages applied to each of the quadrupole rod pairs.  Each RF/dc 
voltage combination will create a stable path through the quadrupole for ions of a certain 
m/z only (such a stable path is shown in Figure 4), with ions of all other m/z values following 
a collisionary path and being neutralised (by collision with the rods) or ejected from the cell 
(by passing out between the rods). 
 
In hybrid instruments with multiple mass analyser stages, the first stage of mass analysis 
within the quadrupole mass analyser can be used for mass scanning where parent masses 
are measured without collecting fragmentation data; however in the time-of-flight or 
orbitrap instruments often used for proteomics it is generally desired to exploit the higher 
mass resolution of these mass analysers to gain accurate mass data for the parent ions (and 
hence greater confidence in their identification).  In this situation the quadrupole functions 
as an ion transfer device in the first stage of mass analysis, creating a stable path for all ions 
within the specified mass range and thus passing them forward to the TOF or orbitrap mass 
analyser for full scan mass analysis of the parent ions. 
 
1.4.3 - Fragmentation stage:- Fragmentation of the parent ions allows more information to 
be gained about the structure of the parent molecule via analysis of the fragmentation 
pattern i.e. the m/z ratios of the fragments formed.  The most common method of ion 
fragmentation used in proteomics is ‘collision induced dissociation’ (CID), occurring within a 
‘collision cell’ containing (most usually) a second quadrupole functioning as an ion 
transmission device, with the RF voltage on the rods such that there is a stable path for all 
ions within the selected mass range of m/z values.  The collision cell is pressurised with a 
non-reactive gas (most usually argon), which is the agent of collision-induced dissociation, 
i.e. fragmentation.  This fragmentation occurs when the analyte ions collide with neutral 
atoms of the collision gas, thus transferring some translational kinetic energy to internal 
energy and placing the ion in an excited state.  If the transfer of energy is sufficient the ion 
will dissociate into characteristic fragments, and the degree of fragmentation can be 
optimised by altering the collision energy applied.  The term “collision energy” refers to the 
application of a dc bias voltage to the gate electrodes preceding the second quadrupole, 
which creates a potential difference between the source and the collision cell and thus 
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increases the translational kinetic energy of the ions as they enter the collision cell.  As the 
translational kinetic energy of the ions increases, so does the amount of energy transferred 
in any given collision and consequently the degree of fragmentation will increase with 
increased collision energy.  Optimisation of the collision energy aims to maximise the 
production of diagnostic fragments – it becomes difficult to resolve the structure of large 
fragments as the possible ion combinations to produce a given m/z ratio increases, and small 
fragments eventually become too common to use in structure elucidation.  To ensure there 
is no crossover of fragments between parent ion masses it is usual for the collision cell to be 
purged of ions between scans by applying a large voltage of the opposite polarity to the rod 
pairs. 
 
1.4.4 - MS-MS analysis (2nd mass analyser):- MS-MS analysis provides information about the 
structural fragments of the analyte molecule, and this information can be used to elucidate 
the structure of the parent molecule.  In protein research and with standard settings 
fragmentation generally occurs first at the amide bonds of the peptide molecules, though 
there is an ongoing area of research to identify fragmentation rules for peptide ions under 
different conditions both during analysis and in the system of interest [33-36].   Within the 
second mass analyser a full scan analysis is performed on the fragment ions passed from the 
collision cell.  In some instruments this geometry is less intuitive in practise, most notably in 
the case of some instruments which interface iontrap and orbitrap mass analysers, where 
ions are passed first to the orbitrap (via the iontrap set to allow a stable path for all m/z ratios 
within the specified mass range) and then back through the collision cell with the resultant 
fragment ions passing into the iontrap for analysis.  This allows the instrument to achieve the 
greatest mass accuracy for the parent ions with the lower resolution iontrap being used for 
fragmentation analysis. 
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1.4.5 - Mass Analyser Types 
 
1.4.5.1 - Time-of-flight (TOF) mass analyser:- The TOF mass analyser measures m/z as a 
function of the ‘drift time’ of a given ion within a flight tube of specific length, when 
accelerated towards a detector under vacuum conditions.   
 
Before entering the flight tube, ions are accumulated in the collision cell via the application 
of a voltage of the same polarity as the analyte ions to the end gate of the collision cell, which 
repells the ions from the gate.  These accumulated fragment ions are then allowed into the 
flight tube to coincide with the next TOF-pulse, by swapping the polarity on the end gate to 
allow the ions to move out of the collision cell. 
 
The TOF-pulse itself is created by the application of a strong voltage of the same polarity as 
the analyte ions to orthogonal accelerator (pulsar) plates - this propels the ions out of the 
end gate towards the detector.  In modern instruments the ions often reach the detector not 
by a linear flight path but via a reflector, or in some cases several reflectors, which serve to 
normalise the energy difference between ions of identical mass but differing kinetic energy, 
and also allows the flight tube section of the instrument to remain physically the same size 
despite increasing the length of the flight path for ions[37].  The reflector itself is a set of 
plates charged with the same polarity as the analyte ions, which ‘reflects’ the ions towards 
the detector by electrical repulsion.  Normalisation is achieved as those ions with higher 
kinetic energy will penetrate further towards the plates and lose their ‘excess’ energy 
through repulsion.  Thus all ions of the same m/z ratio are caused to reach the detector after 
the same drift time within the flight tube.  A schematic of a TOF-analyser containing a single 
reflector is shown in Figure 5. 
 
Once ions are detected, the m/z measurement itself is calculated from the drift time (the 
time between being accelerated by the TOF-pulse and reaching the detector), the 
acceleration voltage applied and the length of the flight tube. 
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Figure 5:  Simple schematic of a TOF tube including a single reflector (as found in the Bruker Microtof Q[38]). 
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1.4.5.2 - Iontrap mass analyser:- The term ‘ion-trap’ describes a group of mass analysers 
including linear and three-dimensional ion-traps.  A general schematic for each of these is 
shown in Figure 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Geometry of the three-dimensional and linear ion-trap mass analyser[39]. 
 
The general principle of both iontrap analyser types remains the same, in that ions are 
trapped within the electrodes as a function of their mass and charge.  By altering the applied 
RF and dc voltages to create potential wells of stability for ions with a selected m/z ratio only, 
the full mass spectrum may be scanned by sequentially ejecting ions of particular m/z ratios 
to the detector.  Alternatively, as a collision gas is present, ions of a particular m/z ratio may 
be trapped, accumulated (with the ejection of all other ions), and fragmented with the 
resultant fragment ions then being scanned out to the detector.  The fact that fragmentation 
and scanning can occur in the same mass analyser allows for multiple levels of analysis, i.e. 
it is possible to excite and fragment the first, second, etc level fragment ions (this capability 
is described as MSn) as well as the original parent ions.  This may be done by selecting the 
m/z ratio of the ions to be trapped and fragmented prior to beginning the experiment, or by 
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allowing the instrument to select for fragmentation those ions that are observed at the 
highest ion intensity. 
 
1.4.5.3 - Orbitrap mass analyser:- The orbitrap mass analyser was introduced by Makarov[40] 
and is a modification of the quadrupole iontrap mass analyser.  It is often interfaced with a 
linear iontrap, which performs the fragmentation stage (as fragmentation within the orbitrap 
is slow) and mass analysis of the fragment ions, with the orbitrap being used due to its ability 
to provide high mass resolution for the parent ions.  The functional principles are similar to 
those which describe the iontrap mass analyser, however an electrostatic field (applied dc 
voltage) only is used to create a stable path for the ions of interest, without the use of RF 
voltages.  The analyser is composed of a spindle electrode and a pair of bell shaped outer 
electrodes, with the pair being separated by a ceramic insulation ring[41].  A schematic 
showing the spindle and bell electrodes, as well as the trajectory of trapped ions within them, 
is shown in Figure 7. 
 
 
Figure 7: Trajectory path of trapped ions within the orbi-trap mass analyser[42]. 
 
Ions which have a velocity vector perpendicular to the spindle electrode, and which obtain a 
velocity of a selected magnitude (applied by the instrument as a function of the m/z ratio 
being recorded in a given scan), are trapped into a stable orbit around the central electrode.  
The axial component of the ion oscillation is detected as an image current on the two halves 
of the bell electrodes.  A fourier transform is then applied to determine the m/z ratio of the 
ions that are trapped.  Once trapped, ions of sequential m/z ratio are released to the detector 
by altering the dc voltage applied to the spindle electrode (in practice a potential is also 
applied to the end-cap or ‘gate’ electrode to regulate the release of ions towards the 
detector). 
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1.4.6 LC-MS Output Data 
 
As the sample passes first through a chromatography column before reaching the mass 
spectrometer, there is chromatographic separation of the individual molecules in the sample 
prior to ionisation.  As each peak i.e. peptide (or group of peptides, when several peptides 
have the same or very similar physico-chemical properties) elutes from the chromatography 
column it passes into the ion source of the mass spectrometer.  Therefore each elution peak 
from the chromatography system contains a “packet” of molecules, which are ionised and 
subsequently recorded at the detector as a peak in the ion abundance.  This is reflected in 
the LC-MS data output, which is known as the total ion chromatogram (TIC)[26].  As the mass 
spectrometer performs scans, it produces one mass spectrum per scan that shows the m/z 
ratios of the ions observed in that scan.  The total ion abundance recorded in each scan is 
shown in the TIC, as a function of the retention time[26]. 
 
From the TIC, it is possible to computationally construct an extracted ion chromatogram (XIC 
or EIC) that shows the elution profile only for those sample ions with a user selected m/z 
ratio.  The XIC can be useful to identify related sample molecules, for example one that has 
been deuterated versus one that has not, that have different m/z ratios but the same elution 
profile.  Using this simple derivatisation strategy it is possible to assess the relative amounts 
of an analyte in different conditions by performing deuterium exchange on only one of the 
samples.  This will give two peaks in the mass spectrum which are separated by a known 
mass difference (deuterium is the 'heavy' isotope of hydrogen, possessing a neutron in the 
nucleus in addition to the proton and electron found in hydrogen and therefore having an 
atomic mass of 2 – this gives rise to a mass shift of 1 mass unit for each deuterium atom 
present when studying singly charged molecules). 
 
The mass spectra recorded throughout the TIC can be viewed and analysed to determine 
which ions are present in each scan[26, 43].  However, rather than a single peak for each ion 
present, the mass spectrum will show an isotope pattern of several peaks.  This is due to the 
presence of less common isotopes present within the molecule at natural ratios, for example 
C13 and to a lesser extent N15.  This isotope pattern includes the monoisoptopic peak, which 
corresponds to the presence of the most abundant isotopes (eg C12 and N14), and less intense 
peaks corresponding to molecules containing less common isotopes (with the relative 
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abundance of the peaks mirroring the naturally occurring distribution of those isotopes 
present).  An example isotope pattern is shown in Figure 8. 
 
 
Figure 8:  An example isotope pattern, for the given protein (generated using the IPC (Isotope Pattern Calculator) 
tool[44]. 
 
Unfortunately, an experimental mass spectrum is unlikely to display a perfect isotope 
pattern for a variety of reasons.  One possible reason for this is that the low abundance peaks 
in the isotope pattern may be obscured by noise peaks of similar abundance, and another is 
that co-eluting analytes may have overlapping isotope patterns that can be hard to resolve 
from each other.  Thus both obtaining chromatography parameters that separate individual 
analytes as much as is possible and ensuring that any computational algorithms are able to 
elucidate isotope patterns reliably is essential to meaningful analysis of experimental data. 
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1.5 - Protein Mass Spectrometry 
 
1.5.1 – Analysis of Whole Proteins 
 
The mass spectrometric analysis of whole proteins may be conducted using ESI, however 
more usually a iso (Matrix-Assisted Laser Desorption Ionisation) ionisation source is used.   
Laser desorption ionisation (LDI) was first introduced in the late 1960s[26], and was readily 
applicable to the analysis of organic salts (low-mass) and light absorbing compounds.  
However there was not utility to apply this method to protein analysis until the late 1980s, 
as it was non-trivial to obtain useful spectra for biomolecules, especially those with mass 
exceeding 2000 atomic mass units.  Two methods were put forward that allowed analysis of 
biomolecules via LDI; the mixture of the analyte (in glycerine) with ultrafine cobalt power, 
and the co-crystalisation of the analyte with an organic matrix (MALDI).  This second method 
gained more use as it gave greater sensitivity and versatility as a technique, though both 
methods are capable of producing useful spectra for molecules with molecular weight up to 
100000 atomic mass units. 
 
A standard sample preparation for MALDI sees the analyte dissolved at approximately 
0.1mg/ml and the matrix dissolved to saturation, or at a concentration above 10mg/ml.  The 
admixture of these two solutions puts the analyte:matrix ratio within the range of 1000:1 to 
100000:1, which is optimal for the production of good MALDI mass spectra.  0.5-2µl of 
sample is deposited on a plate (or MALDI target) to give a thin layer of sample over the 
matrix.  Two methods to achieve this are the evaporation of the matrix solution followed by 
application and evaporation of the sample solution without re-dissolving the matrix, or the 
analyte may be introduced to a pre-prepared matrix using nano-ESI to ionise the sample. 
Ionisation in the MALDI technique utilises laser desorption of sample ions from the surface 
of the matrix.  A laser beam (typically ultraviolet light but infrared radiation may also be used) 
is focussed on a small area of approximately 0.05-0.2mm diameter and the absorption of this 
laser light by the sample layer causes evaporation and then ionisation of the sample atoms.  
The method of ionisation is thought to be a combination of the evaporation of pre-formed 
ions from the matrix and the gas phase photoionisation of evaporated atoms once they are 
within the plasma plume.  The ion source is operated at room temperature and the laser 
Katherine I Mackay 
  19 
attenuation may be optimised for each measurement.  A schematic of the MALDI ionisation 
source is shown in Figure 9. 
 
Figure 9: Schematic of the MALDI ionisation source[26]. 
 
The mass analyser used with the MALDI technique is most usually a TOF analyser (or an FT-
ICR (Fourier Transform Inductively Coupled Plasma instrument, if the analysis of very high 
mass analytes is required).  When an analysis is conducted under specified experimental 
conditions using a MALDI ion source, a so-called ‘peptide mass fingerprint’ (PMF)[45] mass 
spectrum of high mass quasi-molecular ions[46] is produced, which is unique to a given 
protein.  This can then be used diagnostically by comparison with library spectra (in the same 
way that library spectra have historically been used to identify small molecules analysed by 
GC-MS with electron impact ionisation (EI)[47]) to rapidly identify a single protein within a 
gel spot[48], and quantification may be achieved through the use of internal standards of 
known concentration.  The MALDI technique cannot, however, facilitate the identification of 
unknown proteins within a sample mixture such as is required for the analysis of modern 
proteomic data (e.g. to study proteins for which there are no library spectra available such 
as to identify previously unknown proteins within a tissue sample). 
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1.5.2 – Analysis of Peptides as a Method to Identify Unknown Proteins 
 
Previously unidentified proteins in complex mixtures can be detected and sequenced using 
a complex strategy, which involves tandem mass spectrometry utilising the MS-MS 
functionality of hybrid mass spectrometers with a nano-ESI ion source.  Prior to analysis the 
sample protein mixture is digested with a protease enzyme - most usually trypsin, which 
according to the Kiel rule “cuts” the protein at the C-terminal end of arginine and lysine 
peptide residues, but not before proline residues[49].  However cleavages before proline 
have been described experimentally and the suggestion made that excluding the resultant 
peptides from the pool of theoretical peptides may prevent the identification of peptides 
which are in fact present in the sample[49].  In addition, variation in the peptides produced 
following trypsin digestion may be introduced when the protein sample is not completely 
digested leading to “missed cleavages”, where a potential cleavage site is missed giving one 
larger peptide where two smaller peptides would be expected.  Therefore the algorithms 
used must be capable of considering the possible variations to “perfect” digestion.  However, 
it has also been observed that there is no significant difference in precision, accuracy, 
specificity or sensitivity on the inclusion or exclusion of peptides resulting from missed 
cleavages[50]. 
Due to the protease pre-digestion step the mass spectrometric analysis is actually performed 
not on the whole proteins within the original sample, but on the peptides resulting from 
sample digestion and further on their daughter fragments created within the mass 
spectrometer (e.g. from collision induced dissociation within a collision cell), bringing the 
molecules being studied below 3000 atomic mass units. The abundance of the constituent 
peptides in the sample is therefore used as a proxy for the protein abundance present in the 
original sample, making it extremely important that identified peptides are assigned to the 
correct parent proteins.  As peptides are smaller in size there are less possible combinations 
of atoms that account for the recorded mass of these peptides and their fragments than 
there would be for larger molecules, and in addition there are less possible charge state 
combinations.  This makes the task of structure elucidation less computationally demanding, 
and in addition allows further structural information still to be obtained from the 
fragmentation data. 
 
 
Katherine I Mackay 
  21 
Both proteins and peptides are predominantly protonated on the amino groups during 
ESI/nano-ESI, i.e. at the N-terminus and on arginyl, histidyl and lysyl residues[51].  Most 
usually singly charged peptides are observed, though 2+ and 3+ charge states are also 
common[51], and whole proteins have been shown to gain approximately one charge per 
kDa mass[51].  As a general rule for ESI, the signal seen by the mass spectrometer is 
proportional to the concentration of analyte in the sample[26, 51] and this relationship is 
flow-rate independent.  However this relationship may be affected by the ionization 
efficiency of the individual peptides, which can give a more confused picture of protein 
abundance as the intensity of signal from individual peptides may differ even when they arise 
from the same parent protein molecule present at a given true abundance. 
 
During the second stage of analysis within the collision cell the peptides fragment 
predominantly at the amide bonds, producing smaller amino acid chain daughter fragments.  
The main ion types which are produced as a result of fragmentation at standard collision 
energies have been classified as b- and y-ions.  The y-ions arise sequentially from the C-
terminus of the parent peptide ion, with y1 describing the amino acid lost if the first amide 
bond is cleaved and so on.  Correspondingly the b-ions arise from the N-terminus of the 
peptide ion, again with b1 describing the amino acid lost if the first amide bond is cleaved.  
The sites of fragmentation at the amide bond that create both b- and y-ions are shown in 
Figure 10. 
 
 
Figure 10: Peptide fragmentation at the amide bond to produce b and y ions[52]. 
 
There are several reasons making it unlikely that all of these fragment ions will be observed 
in a given mass spectrum, including the differing stabilities of both parent and fragment 
peptide ions within the mass spectrometer, relative bond strengths within the peptides and 
the applied collision energy.  However, those which are observed may be used diagnostically 
to deduce the sequence of amino acids in the parent peptide and hence identify the peptides 
(peptide-level data) and ultimately their parent proteins (protein-level data).  For the current 
Katherine I Mackay 
  22 
study, the terms feature and peptide-level data can be considered synonyms. However, 
there are packages that can treat features and peptides differently, for example in the case 
of two different charge states for the same peptide – where these would be treated as two 
features, but aggregate values used to give a single peptide. 
 
1.6 - Identification of Proteins from Peptide MS-MS data 
 
Though this originally involved de novo sequencing from manual analysis of the data, as is 
done for the analysis of small molecules[24, 53], it is now more usual to use database 
searching software for protein inference.  This increases the automation of proteomic 
experiments and greatly decreases the time required for this step, therefore bringing the 
analysis of hundreds of unknown proteins into the realms of practicability.  A summary of 
the steps involved in this automated process is shown in Figure 11. 
 
Following the practical MS analysis the result files are input to protein inference software or 
scripts for further post processing and analysis.  The software receives as input the m/z of 
parent and fragment ions, the intensity of the fragment ions, plus a text file containing the 
peptide sequences (in one letter notation) for all the known and hypothetical proteins 
expressed by the species of interest – a ‘fasta’ file (compiled from the gene sequence data).  
According to user specified parameters, most essentially the protease enzyme used, 
theoretical peptide spectra are then created within the software for the constituent peptides 
of each protein listed in the .fasta file.  These theoretical spectra are then compared to the 
observed experimental spectra and ranked in terms of how well the two match when 
overlaid.  This sounds simple, but is complicated by several factors including the presence of 
a, c, z and x ions as well as the more abundantly seen b and y ions, and the presence of noise 
peaks that can confuse the isotope pattern of features (by appearing to be one of the peaks 
in the isotope pattern, or by obscuring low intensity “true” peaks) or appear to be peptide 
features themselves.  Therefore the experimental spectrum will always be an imperfect 
match for the theoretical one and there may be several possible matches for any given 
observed spectrum, with the highest ranking (by best match) theoretical spectrum usually 
being assigned as the identity of the peptides present. 
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As the peptides that are identified as present in the data represent a sub-sequence of their 
parent proteins, the presence of those proteins within the sample may be inferred from the 
presence of their constituent peptides.  Each protein in the sample may be represented by 
single or multiple peptides, and there may be ambiguity when a peptide sequence could be 
assigned to multiple parent proteins.  Frequently, a threshold is applied which requires that 
each protein has been inferred from at least two or three quantified peptide features, to 
avoid reliance on single peptide features for identification or quantitation of proteins. 
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Figure 11: Schematic showing the main stages present in a typical proteomics experiment. 
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1.7 - Concatenated target-decoy Database Searching 
 
While it is possible to assign protein probabilities calculated from the peptide probabilities 
of the assigned constituent peptides[54], as implemented in the Trans Proteomic Pipeline 
web based software, it is increasingly common for a concatenated target-decoy database to 
be used so that it is possible to calculate a false discovery rate (FDR)[55] as a measure of 
confidence. 
 
The concatenated target-decoy database is created from original .fasta files containing all 
the proteins predicted from gene models of the organisms being studied (if more than one 
organism is present, e.g. when studying the infection of human cells with a parasite, the 
.fasta files for all the species present are concatenated into one larger .fasta file).  The decoy 
section of the concatenated target-decoy database is most usually created by appending 
either a reverse set of all the proteins in the .fasta file (generated by reversing the peptide 
sequences of the predicted proteins present in the original .fasta file), or a set of artificial 
protein accessions that are assigned to random peptide sequences.  The decoy sequences 
are clearly denoted as such in the target-decoy database .fasta file, most usually by including 
a “Decoy” or “REV” suffix concatenated with the accession number of the real sequence, or 
for randomised concatenated target-decoy databases a “random” prefix with an arbitrary 
unique identifier (such as a letter or a number) may be used.  This method of including equal 
numbers of target and decoy protein sequences in a single file means that there is equal 
competition between the real and the decoy sequences, with no bias towards either group. 
 
The concatenated target-decoy database is searched in the usual manner in order to find the 
best fit theoretical spectra in terms of matching to the experimental spectra.  Many search 
engines now also include an option to set an FDR threshold as a measure of confidence in 
the results returned by that search engine.  The assumption is that if a given number of decoy 
proteins are incorrectly identified to be present in the sample, it can be assumed that the 
same number of “real” predicted proteins will also have been incorrectly identified as 
present by the software.  Where this is not an option built into a software package it is 
possible to calculate a manual FDR by looking for the presence of decoy proteins in the result 
list of protein accessions, using the formula FDR = FP / FP + TP (where FP is the number of 
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observed false positives i.e. concatenated target-decoy proteins and TP is the number of 
observed true positives i.e. real protein accessions).  This method can be useful to determine 
the peptide or protein score that corresponds to the desired FDR, when it is applied after the 
protein list has been sorted by the score of interest, and it is then possible to disregard those 
protein identifications that do not meet this threshold. 
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1.8 - Labelling Techniques in Proteomics 
 
Though this thesis is concerned with the bioinformatics methods used in the context of label-
free proteomics, it is useful to include an explanation of common labelling techniques within 
this introduction to provide context for the term “label-free”.  “Labelling” is the term used 
to describe the derivatisation of the sample molecules in order to differentiate between 
samples from different conditions, e.g. before and after drug administration, and may be 
achieved through in vivo metabolic labelling or in vitro chemical labelling[15].  Each of these 
has its own advantages and disadvantages; in vivo labelling is more efficient and yet 
prohibitively expensive for some studies (e.g. when looking at a whole complex organism 
such as a chicken[56]), while in vitro labelling can theoretically be applied to any sample[15]. 
 
In addition there are several internal standard based labelling strategies that involve the use 
of synthetic or proteotypic (the term “proteotypic” describes those peptides which are 
unique to a given protein, as opposed to those peptides that could be assigned to multiple 
proteins predicted in the sample) peptides as the internal standard.  From the known 
abundance of this internal standard the abundance of experimental proteins can be 
calculated using the relative intensities of the internal standard and the experimental protein 
peaks in the mass spectrum.  Typically the internal standard peptides are synthesised or 
derivatised[19] to give a predictable mass offset allowing for ease of differentiation between 
the internal standard and the peptides of interest.  These internal standard techniques 
include AQUA[20] (internal standard peptides derivatised to give a known mass difference in 
the result data), QconCAT[21] (derivatised peptides concatenated into a synthetic protein 
via bacterial culture) and SISCAPA[22] (derivatised peptides isolated with experimental 
peptide analogues using immobilised anti-peptide antibodies).  As with relative quantitation 
methods, the protein abundance is calculated from the peptide abundance observed for 
those peptides assigned to that protein.  Thus the same challenges of peptide/protein 
inference and abundance calculation are present, and there are a great variety of tools 
designed to address these issues.  However there is no one simple tool that can be applied 
as a standard technique, and therefore this is an ongoing area of research. 
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1.8.1 - Stable Isotope Labelling with Amino Acids in Cell Culture (SILAC) 
 
 
 
Figure 12: Example SILAC work flow. 
 
This type of labelling experiment is particularly useful when studying cells in different 
conditions, e.g. when looking at the effect of drug treatment or the changes following 
infection with a parasite, and a summary of an example workflow is shown in Figure 12.  The 
cells in condition one are grown in standard media and those in condition two are grown in 
labelled media, i.e. media containing the heavy isotopes of one or more element within the 
media such as deuterium or 18O.  The samples from each condition are then pooled together 
for the protein purification, reduction, alkylation and digestion steps.  Running this pooled 
sample through a mass spectrometry pipeline produces a final mass spectrum with paired 
peaks, separated by the mass difference between the labelled and unlabelled peptides.  This 
means that differential expression between the two conditions can then be inferred from 
the relative intensities of the labelled and unlabelled peaks. 
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While the least expensive labelling strategy is to use deuterated amino acids, several other 
labelling atoms are routinely used with the most common strategies using 13C and 15N 
labelled amino acids which give rise to a larger mass shift.  This larger mass shift between 
paired peaks makes it easier to separate out those paired peaks from a complex mass 
spectrum.  As the labelled and unlabelled amino acids experience the same chromatographic 
and ionisation conditions these fold change values are highly reliable and it is this accuracy 
which means that SILAC is one of the most commonly used proteomic techniques. 
 
1.8.2 - Isobaric Tags for Relative and Absolute Quantification (iTRAQ) 
 
This technique concerns the use of commercial iTRAQ reagents, which bind to peptides 
following protease digestion, and like SILAC it utilises the pooling of samples from different 
conditions of interest[57].  The iTRAQ reagents are synthetic molecules which contain an N-
hydroxysuccinimide (NHS) ester derivative which binds to primary amino groups within the 
peptide molecules via an amide bond (this derivatisation at the peptide stage increases the 
complexity of the sample by one to two orders of magnitude and therefore iTRAQ is not best 
suited to highly complex samples).  The NHS reagent also contains a mass balance group of 
carbonyl moeity and a reporter group based on N-methylpiperazine.  The mass balance 
group compensates for the different reporter moieties, ensuring that labelled peptides from 
different conditions appear at the same m/z in the parent mass spectrum.  During MS-MS 
analysis the mass balance group is released as a neutral fragment and the reporter group 
forms an ion which can be observed in the low mass region of the MS-MS spectrum (114-
117m/z[15]).  This use of reporter ions removes the need to extract mass pairs from 
potentially complex spectra, with the fold changes between conditions instead being 
calculated from the relative intensities of the reporter ions.  Originally a set of four iTRAQ 
reagents was available (allowing five experimental conditions to be studied i.e. four labelled 
conditions and one unlabelled condition) but this has now been increased to eight, allowing 
differential expression to be assessed across nine experimental conditions (e.g. nine time 
points in a time course experiment). 
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1.8.3 - Isotope-coded Affinity Tags (ICATs) 
 
The ICAT[58] method also utilises synthetic molecules to derivatise the proteins in the 
sample.  The ICAT reagents have three specific chemical regions: a reactive section, an 
isotopically coded linker section, and an affinity tag.  Once again the technique is designed 
to find differential expression between two conditions, but this time both samples are 
derivatised.  The sample from one condition is labelled with the heavy form of the reagent 
and the sample from the other condition is labelled with the light form of the reagent.  In 
both cases the reagent binds to the side chains of cysteinyl residues in the reduced protein 
samples.  The two samples are then pooled and digested to peptides, and the tagged 
peptides are then isolated by avidin affinity chromatography.  The isolated peptides are then 
analysed by mass spectrometry, with the identification completed as above from the MS-MS 
spectra and the differential expression inferred from the intensity ratios between the heavy 
and light peak pairs in the MS spectra.  While effective, this technique by its nature cannot 
quantify cysteine-free proteins and as the cysteine content of proteins is often low this 
lowers its utility in practice with real samples. 
 
1.9 - Label-free Proteomics 
 
There are two main limitations to the labelling techniques used in proteomics; the first is the 
high cost of labelled media and the second is the large amount of time taken to prepare fully 
labelled biological samples. 
 
Label-free work flows do not carry the increased time requirement and complexity of sample 
preparation that is associated with labelling techniques, however there is an increased 
requirement for instrument time as parallel LC-MS-MS runs of each separate sample are 
required (rather than a single run of pooled samples), and in addition more technical 
replicates are required to manage the greater variability of label-free samples (with respect 
to labelled samples where all the experimental steps are common after samples have been 
pooled rather than processed in parallel).  While this may be a concern if instrument time is 
at a premium (e.g. when many groups share a single instrument), as the LC-MS-MS runs can 
be automated there is time for the analyst to be preparing further samples while awaiting 
the results. 
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Label-free quantitation is achieved via direct comparison of the LC-MS-MS data from several 
runs, and this means that in order to obtain meaningful results it is necessary that the 
instruments used are capable of delivering extremely high mass accuracy and reproducible 
chromatography retention times to allow the separate samples to be accurately compared 
across runs. 
 
1.9.1 - Quantitation Methods 
 
Quantitation for both labelled and label-free methods is typically carried out either via the 
analysis of extracted ion chromatograms (XICs) to give intensity values (as peak height or 
area – these are known as intensity based methods)[59] or by using the number of 
fragmentation spectra matched to peptides as a proxy for the protein abundance in the 
sample (these are known as spectral counting methods)[60].   
 
1.9.1.1 – Spectral Counting Methods 
 
Spectral counting methods are based on the assumption that those peptides present at high 
abundance will be observed as a relatively large peak in the elution profile at the LC stage, 
and are therefore be both more likely to be detected in relatively large number of scans and 
to be selected from a given scan for fragmentation analysis (for example as one of the top 3 
most abundant ions present), and that therefore a count of the observed MS-MS spectra for 
that ion will be representative of the peptide abundance in the original sample (and that this 
will be reproducible in repeat experiments).  The estimated parent protein abundance can 
then be calculated from these peptide abundance values (by taking the sum of all MS-MS 
spectra recorded from peptides which have been assigned to the parent protein)[61-63].  
There are potential flaws in this correlation of spectral counts with protein abundance as the 
differing chemical composition of a proteins constituent peptides causes differing ionisation 
efficiencies within the ion source of the mass spectrometer, potentially making the observed 
“abundance” an average value which may include a high spectral count for peptides which 
ionise well and a low spectral count for those which don’t.  In addition, where peptides of 
similar mass elute together it is non-trivial to determine which peptide a given MS-MS 
spectra should be assigned to.  There have been several attempts to compensate for this 
potential problem by weighting the calculations according to the expected ionisation 
Katherine I Mackay 
  32 
efficiencies based on the peptide properties (hydrophobicity etc) and using machine learning 
techniques, such as in the APEX Quantitative Proteomics Tool[64, 65] (which does both). 
 
 
1.9.1.2 – Intensity Based Methods 
 
Intensity based quantitation is achieved via calculation of the peak height or area for each 
peptide taken from the MS spectra for that parent mass once the peptide has been identified 
from the MS-MS spectra.  The intensity recorded for each peptide will be a summation of the 
intensities for all ions present for that peptide, e.g. 1+ and 2+ ions.  A ratio is calculated for 
each peptide based on the intensities found in each condition, and protein fold change 
obtained from combining the peptide ratios for all peptides assigned to that protein[61].  
This technique requires accurate parent mass values, in order to minimise the issue of 
peptides of similar mass and eluting together (either in the same peak or in overlapping 
peaks) being quantified as one peptide. 
 
Recently, there has been a move towards quantification of label-free data via the alignment 
of accurate mass and retention time across multiple runs to form an aggregate spectrum[66], 
and a typical work flow for this alignment process is described below;  
 
1. Signal pre-processing 
The types of pre-processing required will vary for different datasets, however some of the 
more common steps are noise removal (noise may arise from contaminants in the sample 
or mobile phase, or from electronic noise within the mass spectrometer), baseline 
correction (the baseline is the signal intensity recorded between peaks when no sample 
peaks are being detected, and this intensity can drift up or down over time) and file 
conversion (though noise removal and baseline correction are increasingly redundant as 
instrumentation improves and these steps are incorporated into software packages).  The 
need for file conversion is dependent on the compatibility of the output format from the 
instrument being used with the chosen analysis software, and therefore may not be 
required. 
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2. Feature detection and quantitation 
Peaks present in the TIC are converted to two-dimensional centroid data, and those groups 
of centroid “peaks” which resemble an isotope pattern are selected for analysis[67].  Each 
isotope pattern will be present in a number of consecutive scans, for the duration of the 
elution profile of the chromatographic peak containing the peptide.  Once detected, features 
are quantified by modelling the peak as a Gaussian distribution and calculating the area 
under the curve.  This is broadly correct, however chromatographic peaks will show some 
tailing effects and there are some more complex algorithms which model this behaviour in 
order to achieve greater accuracy.  
 
3. Retention time alignment 
This alignment step aims to remove variation introduced by differences in retention time 
between runs, which could be caused by slight temperature or pressure differences within 
the LC instrument.  The alignment step brings those features with the same m/z ratio to a 
common retention time.  This can be done using either signal or identity based methods[68, 
69]. 
 
4. Collection of peptides across runs 
This refers to the assignment of peptides detected in different runs to the same feature.  
Different approaches have been applied to this task, e.g. Progenesis LC-MS prepares a 
consensus map or aggregate spectrum which combines all runs, while OpenMS collects 
together all post-alignment features that occur within a given tolerance window (e.g. 50s) of 
a selected reference feature[69].  The advantage of an aggregate spectrum is that it can be 
saved into a single file that will be searched against a protein sequence .fasta file in the usual 
manner.  As well as lower time and cost requirements, this label-free method is 
advantageous because the presence of an identified protein in multiple replicates can add 
confidence to the identification of that protein, and in addition if a feature is confidently 
identified in one condition its presence can be inferred in the other conditions (even if MS-
MS spectra have only been collected from one condition).  This inference of peptide identity 
allows differential expression analysis to be performed on the data even when peptides are 
at very low abundance in some conditions and therefore have not been selected for 
fragmentation analysis in those runs. 
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5. Peptide identification mapping 
At this stage the identified features are tied to theoretical peptides generated as constituents 
of those proteins which may be present in the sample, via the accurate mass values assigned 
to the features (see pages 21-23). 
 
6. Peptide to protein quantitation inference 
For label-free methods protein quantitation is usually inferred from the summation of the 
intensity values assigned to the constituent peptides of that protein, though a mean value 
may be used.  For SILAC (see pages 26-27 for a detailed discussion of the SILAC method) a 
median ratio is normally used.  When peptides cannot be resolved to a single protein it is 
usual to assign and quantify a protein group instead, to avoid discarding data. 
 
7. Intensity normalisation 
A normalisation step is necessary as the total ion count will vary from run to run, and 
therefore the signal intensities reported from each run (being a proportion of the total ion 
count) will also vary.  Normalisation steps aim to minimise this variation so that the separate 
runs are comparable, using either internal standards or statistical methods.  One possible 
statistical method (which is used later in this thesis – see page 36) is median absolute 
deviation (MAD) normalisation[70].  The intensity normalisation step has the potential to 
greatly affect the intensity values calculated for peptides, and hence proteins, and therefore 
optimisation of this step is extremely important.  Since the work presented in this thesis was 
conducted, there have been several studies which have looked at optimising the 
normalisation step[71-73]. 
 
1.9.2 – Available Quantitation Software 
 
As previously mentioned there are many software packages available to post process and 
analyse proteomic LC-MS-MS data, including vendor software (e.g. ProteinPilot™ from ABI, 
ProteinScape™ from Bruker, BioWorks™ and Sieve™ from Thermo, and the ProteinLynx 
Global Server™ from Waters), commercial software (e.g. Progenesis LC-MS) and software 
which is open source (e.g. MaxQuant)[74-82].  Though the open source software is freely 
available, it is generally also specific to a type of instrument platform, a particular 
experimental procedure[15], or to a specific combination of both.  The open source software 
provision is important for those analysts who do not have access to any vendor software, or 
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who wish to use in house or third party search engines.  For those who wish use the same 
software across multiple instrument platforms it is important that there are software 
packages which are not instrument or input format specific, and packages such as Progenesis 
LC-MS are becoming more universal as they work to provide this.  One issue arising from the 
large range of software packages available is the lack of standardised data formats, meaning 
that not all software packages can be used to analyse data from all platforms and therefore 
this must be considered when designing an experimental pipeline.  However conversion 
scripts/software is emerging to allow simpler transition between data formats, allowing 
more freedom for analysts to choose a preferred search engine and processing software with 
which to analyse their data and making comparison between results from different platforms 
possible[15] and indeed practicable. 
 
In addition to post-processing software the high complexity of samples where the ground 
truth is unknown means that benchmarking studies using sufficiently complex and truly 
representative standard datasets are increasingly important in order to add confidence to 
the methods used and hence to the biological conclusions made from the experimental 
results.  As the creation of such standard datasets is extremely non-trivial, it will be highly 
beneficial to the field if these datasets once created are made freely available from online 
repositories, such as the NCCR Yeast Resource Centre Public Data Repository[4], PRIDE[5], 
the Global Proteome Machine Database (GMPdb)[6], PeptideAtlas[7], MassIVE (UCSD)[8], 
or Tranche[9], as the availability of good datasets will allow a greater number of 
meaningful benchmarking studies to be conducted by bioinformaticians and 
experimentalists who may not have the expertise, time or equipment required to design 
and prepare the complex standard samples themselves.  This ready availability of 
proteomics datasets in standard open-source formats is the aim of the ProteomeXchange 
(PX) consortium[10], which currently includes PRIDE[5], PeptideAtlas[7] and MassIVE 
(UCSD)[8].  Another consideration of great importance is the need for long term stability of 
proteome repositories to avoid the loss of datasets, for example many researchers 
deposited raw data into Tranche, which then lost financial support resulting in many data 
sets becoming corrupted or being lost altogether.  Therefore an additional goal of the PX 
consortium is to ensure that such a situation cannot happen again, so that researchers can 
be confident that datasets will be robustly stored for the foreseeable future. 
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2 - Quantitative Proteomics Software used in Combination to 
Reduce False Discovery Rate 
 
2.1 - Aims 
 
This software comparison study aims to determine how much variability is introduced into 
final results through the use of different software pipelines to analyse the same data set, in 
terms of the number of proteins reported as differentially expressed, which proteins are 
identified/quantified, and the false discovery rate for each pipeline.  As well as comparing 
and contrasting results from individual pipelines, the pipelines used allow comparison of 
intensity-based label free pipelines versus spectral counting pipelines, and in addition this 
study examines the potential of creating a consensus method which takes data from all 
pipelines to produce a more robust result than any single pipeline alone. 
 
2.2 - Introduction 
 
The move from identification to quantitation proteomics has become increasingly 
widespread as mass spectrometry instrumentation has become more capable of delivering 
accurate mass information.  This is particularly important as peptides often overlap in LC-MS, 
and low resolution instruments cannot resolve the data to individual peptides, leading to 
poor quality quantitation. As a result of this increased use of proteomic pipelines and desire 
for quantitative results, the associated software techniques have also become more 
sophisticated – delivering more accurate data for large numbers of proteins.  This study 
compares and combines the results obtained from the parallel analysis of a single dataset 
using four separate software pipelines for protein identification and quantification.  This is a 
question of relevance to the field as little work has been reported on this type of comparison, 
yet the assumption of comparability for results obtained by different groups using different 
pipelines is implicit in the comparison of the biological conclusions presented by analysts.  It 
is intended that this study will provide information for analysts as they design their 
experiments, and give an insight into the challenges that are encountered when deciding on 
the instrument platform and post-processing methods which are appropriate to their aims. 
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The quantitation methods considered in this study are; emPAI[83] values generated within 
and reported by Mascot (Matrix Science), spectral count and intensity values reported from 
Progenesis LCMS (Non-Linear Dynamics), absolute protein expression values from the APEX 
quantitative proteomics tool[64, 84] (following processing using the Trans-Proteomic 
Pipeline[85] web interface), and intensity values from MaxQuant[86] (open source).  Very 
little work has been done where this type of comparison has been made between different 
spectral counting and intensity based software pipelines[87], with discussions of this type 
largely restricted to the presentation or comparison of novel in-house pipelines with those 
which are more widely used (both intensity based[88-92] and spectral counting based[93, 
94] workflows) rather than an assessment of the software pipelines that are available to the 
standard user.  Despite this, an investigation of the reliability of those software pipelines 
used for the analysis of proteomic data is an extremely important research question, and 
increasingly so as these methods become more widely used, and the biological questions 
asked by these analyses becomes more complex. 
 
Each workflow pipeline was used with all parameters set at the default settings (i.e. those 
settings recommended in the software guidelines), apart from those parameters that were 
experiment or instrument specific.  These inherent parameters (eg mass tolerance, allowed 
modifications, the number of missed cleavages allowed and the .fasta database searched for 
identifications) were set identically across all software in order that the results were 
comparable.  The results from all pipelines were then compared to evaluate the conformity, 
reliability and reproducibility of the data obtained from and between different processing 
and experimental workflows when using a standard dataset for all analyses.  In order to 
complete the comparison an assessment was made of any gains obtained by combining the 
results of multiple pipelines, in terms of improving the ratio of sensitivity to false positives  
for differentially expressed proteins (analogous to the gains observed when using multiple 
search engines for protein identification[3]). 
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2.2.1 - Datasets studied 
 
2.2.1.1 - ABRF iPRG2009 
This dataset was created for an iPRG (Proteome Informatics Research Group) study 
conducted by the ABRF (Association of Biomolecular Resource Facilities)  in 2009, the primary 
goal of which was to “Evaluate protein differentiation tools for MSMS”, with the additional 
secondary goal to produce a “benchmark reference” of ‘true’ proteins which could then be 
used as a basis for software development”[95].  Thus the study was not intended to be 
quantitative, and therefore the dataset was not constructed with complete quantitative 
analysis in mind.  Thirty different labs took part in the 2009 study, and between them they 
returned 37 submissions of results.  Each submission detailed which proteins had been 
assigned as significantly changed between the two conditions studied, plus a score showing 
the confidence placed on each reported protein assignment. 
 
In order to create the “standard known dataset” to be used in the study an E.coli digest 
sample was split and run in parallel using 1D SDS-PAGE on two parallel lanes of the same gel.  
Sections of these gels were then excised to create artificial up and down regulation between 
the two conditions, and these sample conditions were then arbitrarily labelled as ‘Red’ and 
‘Yellow’.  All gel sections were reduced and alkylated, followed by an in-gel digestion with 
trypsin.  The resulting final samples were then run in 5 parallel runs on a low resolution 
Thermo Finnigan LTQ mass spectrometer and the output MS and MS-MS spectra distributed 
via the Tranche tool[9] in .raw, .mzXML, .mzML, .mgf and .DTA data formats.  The tranche 
tool was an interface to search and access the resources hosted on the Tranche server, and 
the data from this study was presented on the server as a downloadable folder containing 
all the .raw data and a .fasta database file, which was compiled by concatenating .fasta files 
containing BSA (Bovine Serum Albumin), common contaminants and reverse sequences to 
the SwissProt E.coli database .fasta file (as accessed on the 3/6/2008).  In order to generate 
an unbiased Answer Key (to be used to evaluate the results returned from the groups and 
laboratories taking part in the ABRF study) the ABRF group performed three parallel runs of 
the excised gel sections (which contain the proteins that will be “missing” from the ‘Yellow’ 
and ‘Red’ samples), with these artificial conditions labelled as ‘Blue’ and ‘Green’.  The results 
were then analysed in parallel by 10 ABRF research group members.  92% of the Answer Key 
is made up of proteins which were agreed upon by at least 5 group members, with the 
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remaining 8% made up from proteins which were agreed upon by a minimum of 2 group 
members and fell within the expected mass range. 
 
2.2.1.2 – CPTAC Study 6 
This standard dataset was created for CPTAC (Clinical Proteomic Tumour Analysis 
Consortium) study 6[96] (published October 2009), which was a benchmarking study seeking 
to provide a basis which would allow groups to self-assess the performance of their 
instrumentation and post-processing procedures on a standard dataset where the ground 
truth is known.  The dataset presented consisted of five samples which were the result of 
splitting a single yeast culture, with the intention to obtain a truly homologous sample as the 
basis for the prepared standard samples, so that the only difference between the final 
samples would be the level of spike-in proteins added.  Creation of this single culture for use 
in the study was outsourced by the study group, and was conducted as follows; “S. cerevisiae 
strain BY4741 (MATa, leu2_0, met15_0, ura3_0, his3_1) was grown in a 10-liter batch of rich 
(yeast extract peptone dextrose) medium at 30 °C in a fermentor to an A600 of 0.93”[96].  The 
sample was then passed back to the study group as a lyophilised yeast lysate, which was 
reconstituted, reduced and alkylated prior to trypsin digestion.  Following digestion the 
sample (dried digest re-suspended to a concentration corresponding to ~60ng/µl yeast 
protein before digestion in 0.1% aqueous formic acid) was split into five smaller samples, 
each of which was spiked with different levels of a standard protein mix (which had also been 
pre-digested with trypsin).  The mix used was the Universal Proteomics Standard 1 (UPS1) 
standard mix from Sigma-Aldrich[97] (an equimolar protein mix with all proteins present at 
5pmols), which was spiked in at a level corresponding to concentrations of 0.25, 0.74, 2.2, 
6.7 and 20fmol/µl total protein pre-digestion.  This methodology is summarised below in 
Figure 13. 
 
The resulting five spiked samples were designated A-E (with A containing the lowest and E 
the highest concentration of spike-in proteins) and sent out to a number of expert labs where 
the samples were run in triplicate on various ion-trap based MS platforms (LTQ, LTQ-VELOS, 
LTQ-VELOS Orbitrap and LTQ-Orbitrap) following a standard operating procedure (SOP) 
which was distributed with the samples.  The full LC-MS parameters contained in the SOP 
can be found in the supplementary material for the CPTAC Study 6[96].  The results files 
generated from the various MS runs in the external laboratories were then returned to the 
study group for analysis.  The resulting paper[96] reported that fold changes could be 
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quantified accurately for the UPS proteins, but that these proteins could not be detected in 
the A sample (hence only samples B-E are used in this analysis), and that the yeast proteins 
were not seen to be significantly changing between the 5 samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: CPTAC samples were created by splitting a single yeast digest into five and spiking each with protein mix (0.25, 0.74, 
2.2, 6.7 and 20fmol/ul respectively for samples A-E). 
 
The study group made the .raw spectra from the analyses by all groups available as Thermo 
.raw files via the Tranche tool[98].  However, for my study only one of these datasets was 
used – this was the dataset resulting from the analysis using a Thermo LTQ Orbitrap (the 
dataset designated “LTQ-OrbitrapO@65”, in which the 65 represents the laboratory which 
completed the analysis) - as this was seen to yield the highest number of peptide spectrum 
matches for yeast proteins. 
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2.3 - Methods 
 
For ease of reference, a workflow diagram has been prepared which summarises the work 
that has been carried out in the course of this study and this is presented below in Figure 14. 
 
 
 
Figure 14: Workflow diagram showing the different stages of analysis for the ABRF and CPTAC data 
 
2.3.1 - FASTA files used 
 
2.3.1.1 – ABRF iPRG2009 data 
The official .fasta file distributed via Tranche was used for the analysis of this dataset, with 
the same .fasta file being input to all software analysis pipelines. 
 
2.3.1.2 - CPTAC Study 6 data 
The .fasta file for this dataset was created by concatenating two FASTA files – the current 
yeast open reading frames transcript downloaded from the Saccharomyces Genome 
Database (downloaded early 2010) and an official database containing the sequences of the 
48 UPS1 proteins. 
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2.3.2 - Software packages used 
 
2.3.2.1 - emPAI calculation 
.fasta files were searched using an in-house Mascot server with the following settings: allow 
1 missed cleavage, fixed modifications: Carbamidomethyl (C), variable modifications: 
Oxidation (M)*, Peptide Tolerance: +/-10ppm, MS-MS tol. +/-0.6Da (the fixed and variable 
modifications are set as a function of the experimental preparation).  The emPAI values used 
were those exported directly from Mascot.  The emPAI value is a modification of simple 
spectral counting, the basic assumption of which is that if a protein is abundantly present all 
the constituent peptides of that protein will be observed during mass spectrometry.   In order 
to determine the emPAI value, the PAI (protein abundance index) is first calculated by 
dividing the “observed” value by the “observable” value for each protein in a sample, where 
the observed value is the number of non-redundant peptides identified (allowing multiple 
charge states for each peptide) as experimentally associated with that protein and the 
observable value is the number of peptides per protein predicted from a theoretical digest 
which are within the defined scan range of the instrument (in the Mascot implementation 
this range is not simply that set by the user, but is dependent on the highest and lowest m/z 
values detected experimentally i.e. any theoretical peptides above or below these will not 
be included in the observable value used in the calculation). The emPAI value is then 
calculated from the PAI as  
𝑒𝑚𝑃𝐴𝐼 = 10
𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑
𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑏𝑙𝑒 
 − 1. 
 
*The fixed modifications set are a function of the experimental procedure conducted in the sample 
preparation, namely reduction and alkylation.  The variable modification of oxidation on methionine 
is set as this is a common post-translational modification and it is desired to record any proteins 
whether they have this modification or not. 
 
2.3.2.2 – APEX Quantitative Proteomics Tool 
The APEX tool is also a spectral counting based method of scoring protein abundance similar 
to emPAI.  In this quantitative method peptides are considered more or less likely to be 
observed by mass spectrometry based on their physico-chemical properties and their 
resulting predicted behaviour within the mass spectrometer.  The input for the APEX tool are 
.protXML files output from the TransProteomic Pipeline (TPP), therefore the files used in this 
study were pre-processed within the TPP web interface prior to analysis with the APEX tool.  
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In the TPP web interface the files were converted to .mzXML and the in-house Mascot server 
used for the searches (with the same parameters as above).  The Mascot result files were 
then converted to .pepXML files and these were run through the next stage of the TPP, 
PeptideProphet, with the option selected to run ProteinProphet afterwards (using pI, 
hydrophobicity and RT information, and including results with pepProphet probability <0.05 
and minimum peptide length = 7).  The final .protXML files were then analysed using the 
APEX tool.  One .protXML file was selected to be used for training (using the default random 
forest machine learning algorithm[99], which is considered to be the most appropriate 
training mechanism for APEX), with reference to the relevant .fasta database file, using the 
default settings (Consecutive Misses: 0, Use Minimum Peptide Length: 3, Use Minimum 
Peptide Mass: 250, Use Maximum Peptide Mass 7500, P(i)=1.00, APEX normalisation factor 
= 0.00) and with all the available peptide properties used to assess the ionisation efficiency 
of theoretical peptides.  This creates an .ARFF file of training data, which is then used with 
the relevant FASTA file to create an .oi file.  This .oi file stores the signal intensity and physico-
chemical properties of the peptides found in the training file, and is used as the reference 
for the analysis of other sample files.  The APEX scores are internally calculated using the 
following formula. 
 
ni = observed spectral counts 
pi = protein identification probability 
Oi = predicted count for one molecule of protein 
(sum of peptide detection probabilities) 
 
The APEX score, pi, ni and oi are reported in the APEX output .csv file, which can easily be 
copied into Excel for post-processing. 
 
2.3.2.3 - Progenesis LC-MS (Nonlinear Dynamics Ltd) 
Thermo .raw files were loaded into the Progenesis LC-MS software (version 3.0.3840.17781) 
and all samples aligned to the E1 sample using automatic alignment. The resulting aggregate 
spectrum was then filtered to include +1, +2 and +3 charge state features only.  In the 
experimental design tab within Progenesis LC-MS the samples were grouped according to 
the experimental conditions (B-E), and features without MS2 spectra were deleted from the 
analysis (as MS2 information is necessary for peptide/protein identification).  An .mgf file 
representing the post-alignment aggregate spectrum was exported and searched using 
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Mascot (with all settings as detailed above).  The resulting .xml file was then re-imported to 
Progenesis LC-MS to assign peptides to features.  Two different thresholds were used while 
importing these identifications, reflecting changes to the guidelines offered by the software 
manufacturers.  First, a threshold of Mascot score≥40, hits>2 was applied, as recommended 
in a tutorial from NonLinear Dynamics.  The analysis was also completed using a Mascot score 
threshold ≥ 17, as this is the value given by Mascot above which a given protein is confidently 
identified within this data set.  The “Protein Raw Abundance” data type was then used for 
post-processing. 
 
2.3.2.4 - MaxQuant 
The Thermo .raw files were analysed within the Quant.exe (version 1.1.1.36) program of the 
MaxQuant software, using the appropriate .fasta files and the following parameters: Parent 
tolerance +/- 10ppm, Variable Modifications: Oxidation (M), Fixed Modifications: 
Carbamidomethyl (C), CID MS-MS tolerance: 0.6Da (using 6 top peaks per 100Da, Higher 
charge and allowing water and ammonia losses), Time correlation: 0.7s, Peaks per 100Da: 
20, SIL weight: 4, ISO weight: 2, Low mass cutoff: 0, Peptide/Protein FDR: 0.01, Using 
unmodified, Oxidation(M) and Carbamidomethyl(C) peptides for quantification and “Using 
Unique Peptides”, Keep low-scoring versions of identified peptides, Match between runs: 
Time window 2 mins.  The resultant .txt files were saved in the .csv format for post-
processing in Excel. The “LFQ Intensity” data type was used for post-processing as it has been 
observed to be a more accurate measurement of the true ratios present[100]. 
 
2.3.3 - Median Absolute Deviation Normalisation (Intensity based methods) 
 
All calculations involved in this normalisation procedure were conducted manually in 
Microsoft Excel, in a manner based upon the method used for Progenesis LC-MS as described 
by Non-Linear Dynamics[101].  In brief, log ratios were calculated for each replicate relative 
to the E1 sample (chosen since condition E contains the highest concentration of spiked UPS 
proteins and it is therefore assumed that all UPS proteins that can be detected should be 
identified in this replicate).  The median log ratio for each replicate (ie for each column in the 
Excel spreadsheet) was calculated.  Next, deviations from the median log ratio in each 
replicate were calculated for every protein and these values used to calculate the median 
absolute deviation (MAD).  This is the median of the calculated deviations from the median 
log ratio, and is calculated for each replicate separately (i.e. there is a MAD value for each 
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column).  Log ratios which were not within one MAD of the median value for a given replicate 
were removed as outliers and the remaining values used to calculate a scaling factor for each 
replicate, which is calculated as the inverse of the mean log ratio per column (calculated 
following outlier removal). 
 
2.3.5 - Total Count Normalisation (Spectral Count based methods) 
 
Median absolute deviation normalisation is not appropriate for spectral count derived 
abundance values, since many low abundance proteins produce identical emPAI or APEX 
values in different conditions (giving a log ratio of 0), and this leads to skewed normalisation 
factors when MAD normalisation is used.   Therefore for spectral count based methods it 
was decided to use the simpler Total Count Normalisation method, with this calculation also 
conducted manually in Microsoft Excel.   The total summed protein abundance value was 
calculated for each replicate (ie each column in the spreadsheet) and all replicates 
normalised against the replicate which gave the highest total abundance value (for the APEX 
data this was C3, and for the emPAI data E1).    The scaling factor for normalisation was 
calculated as Sf = 
total h
totali
  where totalh is the highest column total value and totali is the total 
abundance for a given column.   Scale factors were then used to calculate the normalised 
abundance values for each column as above. 
 
2.3.6 - Thresholds applied for inclusion of data for analysis 
 
Prior to the application of a statistical test to identify differentially expressed proteins, it is 
important to remove low quality data from the analysis to avoid the skewing of the results 
by incorrectly assigned features.  Thresholds were set appropriately for each type of data 
and post-processing method. 
 
2.3.6.1 – Heatmap Data Thresholds 
Less stringent thresholds were applied to the protein lists to allow more proteins to be 
included in the generation of heatmaps, these thresholds required only that each protein 
had been quantified by at least two software packages and in both the conditions being 
considered.  This was considered reasonable as the generation of heatmaps was intended as 
a means to investigate the agreement between packages in terms of which proteins were 
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identified as differentially expressed, rather than an a measurement of quantitation 
accuracy. 
 
2.3.6.2 – Thresholds for inclusion in pseudo-ROC plots 
For the intensity-based data the threshold was set to require that the protein had been 
quantified using 2 or more unique peptides (the unique peptides metric is reported by both 
MaxQuant and Progenesis).  This threshold is considered sensible as there is risk in using a 
single peptide to represent protein-level quantitation because any errors in feature 
detection, map alignment or identification assignment, etc, will be directly reflected in the 
results.  Through the use of more than one peptide, such inaccuracies are mitigated. 
 
However there is no information about unique peptides included in the results data from the 
spectral counting methods and therefore the threshold of two unique peptides cannot be 
used in this case.  Thus for the spectral count data, since an emPAI or APEX abundance value 
calculated from a small number of peptide counts would be low quality for the reasons given 
above,  the data matrix was ranked by percentile and a threshold set which excluded the 
lower 50% of data.  This threshold is somewhat arbitrary but was set to avoid protein ratios 
derived from small numbers of spectral counts being included in the final results.  It was 
observed that this was the lowest proportion of the data which could be removed in order 
to exclude all of those proteins which were detected in only one of the fifteen condition 
replicates.  The rationale for this threshold is that those proteins that are present at a 
significant abundance in the original sample should produce peptides which are present at 
detectable abundance in at least two or more conditions and/or replicates. 
 
Both these threshold protocols were considered sensible for the two data types and though 
they are not strictly directly comparable it was considered that a “real” comparison of data 
with appropriate thresholds applied was more appropriate to the questions asked by this 
study (aiming as it does to look at the comparability of data obtained from different analysis 
pipelines used in different labs, where the data from each pipeline will have been processed 
optimally for each individual study). 
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2.3.7 - Tests for differential expression  
 
Three different “scores” were used to identify proteins as differentially expressed; p-values, 
absolute fold change and QPROT-FDR.  The p-values (obtained from two-tailed Student’s t-
tests conducted on the data in Excel) and absolute fold changes were calculated from the 
protein abundance values reported for each replicate.  Each score was calculated as a 
pairwise comparison between the conditions (E/B, E/C and E/D), for each of the four 
software packages.  In addition, the data was processed through the QPROT tool [1, 2], which 
has been designed specifically to calculate accurate statistics, such as FDR or Z-statistic 
values, for differentially expressed proteins in label-free spectral counting and intensity data. 
The QPROT tool[1] is a Linux based tool, which is a further development of the QSPEC 
tool[102, 103] that uses Bayesian statistics to model the likelihood of true differential 
expression in label-free data.  The QPROT-FDR from the QPROT output was used as the 
chosen score to order proteins for the pseudo-ROC plot comparison using this “score”. 
 
2.3.8 - Calculating FDR and sensitivity for pseudo-ROC plot generation 
 
To calculate an FDR each table of results was ordered by the chosen “score” (pvalue, fold 
change or QPROT-FDR) of interest, and the FDR was calculated from: FDR = FP / FP + TP, 
where TP is the count of UPS proteins with the given score or better and FP is the count of 
all non-UPS proteins with the given score or better.  Sensitivity was calculated as sensitivity 
= TP / 48 (as there were 48 UPS proteins in the UPS1 protein mix spiked into the CPTAC 
samples) and q-values were calculated by finding the lowest FDR that could achieve the same 
sensitivity or better for the score of interest.  Therefore, for every row of data there is a q-
value and an associated sensitivity, and these were plotted as “pseudo-ROC” plots (shown 
below – these are referred to as pseudo-ROC because a ROC (Receiver Operating 
Characteristic) plot typically displays true positive rate versus false positive rate so these 
plots are a variation on the norm).  These plots provide a measure of test accuracy, with a 
plot that follows the left and top border of the space closely indicating high accuracy, and 
show the effect on sensitivity when different q-value thresholds are applied. 
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2.3.9 - Consensus across different packages 
 
A straightforward method was sought to compare the results from the different software 
packages in order to assess whether there was a consensus in the data.  A consensus 
between packages would make it possible to test the hypothesis that the consensus results 
will give a better measure of differential expression than any single package alone.  This 
hypothesis follows the logic behind improving sensitivity in peptide/protein identification 
through the use of multiple search engines[3, 104], and extends it to quantitative analyses.   
The methods chosen to investigate this hypothesis were heatmaps of the data, and pseudo-
ROC plots generated using the QPROT Z-statistic.  Both the heatmaps and the the pseudo-
ROC plots were generated using the R statistical package. 
 
2.3.9.1 - Heatmap generation 
Log10 ratios were calculated between the E/B, E/C and E/D conditions and the maps 
constructed using the heat map.2 package in Bioconductor, which is a supplementary 
statistical package for R.  Parameters were set to use the hierarchical clustering function 
(hclust) as the distance/linkage algorithm to generate the heatmaps.  Null and infinity values 
cause problems for calculating dendrograms, with a null value occuring when the protein is 
undetected in both conditions being compared, and an infinity value being reported when 
the protein is detected in only one condition.  In both cases these were set to zero, and those 
rows containing only zeros were excluded as no conclusions could be drawn from the data 
for these proteins.  The scale was fixed so that a zero mean gives black, with up-regulation 
giving green and down-regulation giving red areas in the heatmap. No optimisation was 
performed on the parameters used within R to create the dendrograms and no additional 
thresholds were applied to exclude unreliable data, since we wished to test how well this 
method would perform in the absence of optimisation which would be difficult for the 
standard user to perform in a real situation where the ground truth would obviously not be 
known.  The generated heatmaps can be used both as a method to compare the results 
between pipelines in terms of presence and magnitude of up/down regulation, but can also 
represent a consensus method giving greater confidence to those proteins that are assigned 
as similarly differentially expressed by multiple pipelines. 
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2.3.9.2 - QPROT Z-statistic 
This method of comparison used the more stringent thresholds detailed above in 2.3.6.2.  
The Z-statistic itself is a measure of the distance (in standard deviations) from the mean in 
normally distributed data.  The QPROT tool analyses the global distribution of the data from 
each software package and thus multiple Z-statistic values are broadly comparable across 
the different packages.  If a given protein had not been measured by a particular package, 
the Z-statistic for that package was scored as zero to denote that there was no evidence for 
differential expression. 
 
As the Z-statistic values are comparable across packages, the absolute value of the mean Z-
statistic was taken in order to combine the results from the four software packages, bringing 
all data onto the same scale as the absolute value is an approximation of the global strength 
of differential expression (either up or down) as calculated by each of the different packages.  
These values were also plotted on the pseudo-ROC plots to assess this combination method 
as a way to improve sensitivity with respect to the plots from each individual package. 
 
2.4 - Results 
 
Both datasets were analysed using four different software pipelines in order to test how well 
each software package could detect the known underlying ratios present within the data, to 
assess the agreement between pipelines, and to estimate the FDR associated with different 
methods of determining which proteins were differentially expressed between conditions.  
Heathmaps and pseudo-ROC plots were used to compare the results obtained from the 
different software packages and assess any agreement on the direction and magnitude of 
differential expression between conditions.  An attempt was also made to combine the 
results from all software packages to determine if a consensus method would improve the 
sensitivity while reducing the number of associated false positives. 
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2.4.1 – ABRF data 
We analysed the ABRF data set (yellow/red comparison) to see how well the different 
software packages agreed. First we looked at the proteins that were scored as significantly 
changing (p<0.05) by each of the software pipelines and were contained within the answer 
key. Across the different pipelines, over 500 proteins were scored as significantly changing, 
with only 22 proteins being common across all pipelines, thus showing the general 
agreement between pipelines was poor. The same analysis was repeated for the fold 
change data, and this gave a slight increase in the number of common proteins, but still 
showed no general agreement in the overall picture. A heat map of the five pipelines (at 
this stage we were also considering the spectral count values reported from Progenesis, 
however this metric was dropped from further analysis) for the log ratios of yellow over red 
is shown in Figure 15.  A clear trend emerges from the heat map that there are two clusters 
of proteins, one showing clear up-regulation (green – 14 proteins) and one showing down-
regulation (red – 20 proteins).  As the published “answer key” does not include differential 
expression information the ground truth for the ABRF dataset is unknown.  However, the 
results from the heat map are likely to be relatively robust with a lower FDR with respect to 
using a single software package, since each software package is likely to introduce a unique 
set of errors, and any bias introduced by using a single package should be removed by 
considering the consensus results.  On considering the heatmap it can be seen that there 
are a number of proteins where different packages give opposite results – and therefore 
there is little confidence in the identification/quantitation of these proteins. It is possible 
that one package is “correct” and the other “incorrect” which could be deduced by careful 
manual analysis, but creating heatmaps of the results as a first pass allows the lab scientist 
to focus first on those proteins where there is a high confidence that differential expression 
is truly present. 
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Figure 15: Heatmap showing differential expression results for the ABRF dataset, including zoomed section showing protein 
accessions (Columns are “Spectral Count” (from Progenesis), “APEX”, “Progenesis”, “emPAI” and “MaxQuant”) 
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Following the analysis of those heatmaps generated from the ABRF dataset it was concluded 
that the setup was too artificial, and as the true real answer is unknown it is impossible to 
draw any conclusions about software quality based on the analysis of this dataset with any 
confidence.  As such further stages of analysis were not completed for this dataset. 
 
2.4.2 - CPTAC ratio calculation 
 
Ratios were calculated for the spiked in UPS proteins in the CPTAC dataset to compare the 
experimental ratios with the known ratios between the spike-in amounts for the E/B (27 fold 
change), E/C (9 fold change) and E/D (3 fold change) comparisons, using the four software 
pipelines: emPAI, APEX, Progenesis LC-MS and MaxQuant.  It was observed (see Figure 16) 
that the two intensity based pipelines gave greater accuracy as measured by the median 
protein ratios.  Progenesis LC-MS gives the closest median ratio values to those expected 
from this dataset, 26.8, 10.3 and 4.1 for raw values and 20.8, 8.5 and 3.0 after normalisation 
with the expected values being 27,9 and 3.  MaxQuant also produced relatively accurate 
ratios in the raw data, 34.2, 8.2 and 2.7, but this time normalisation appears to increase the 
ratios, to 49.6, 11.7 and 3.2.  Both intensity-based packages produce similar values for the 
interquartile range of the data.  This indicates that the relative spike-in has been done 
correctly across the different samples; however there are inherent differences in the 
abundances of proteins present in the yeast background.  Differences in the yeast 
background can also be observed in box plots of the yeast log ratios before and after 
normalisation for each package. 
 
The two spectral counting methods underestimate the ratios in all three comparisons.  Given 
that Progenesis LC-MS and MaxQuant (raw abundance) are able to broadly measure the 
correct ratios without normalisation steps, we can assume that there is a feature of the 
underlying spectral count method that is inaccurate, at least for the analysis of this dataset.  
However, as neither emPAI nor APEX were designed for accurate calculation of ratios across 
multiple conditions, this result is not entirely unexpected.  Both emPAI and APEX involve 
putting the spectral count values onto an exponential scale, and it may be that this 
relationship does not hold for this dataset, or for a certain subset of the proteins within.  For 
emPAI, the calculation uses observed (peptides)/observable and therefore to get a high 
dynamic range you would need to observe the majority of the peptides within a given 
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protein. For many proteins it is likely that a subset of their constituent peptides will have 
physicochemical properties that lead to poor ioisation, and thus high emPAI values cannot 
be seen for those proteins. 
 
It was observed for this dataset (see Figure 17) that while the raw values for UPS proteins 
are broadly accurate in each MS run, there are differences in the global abundance of yeast 
proteins (which are expected to be in 1:1 ratios across all conditions). 
 
Applying normalisation to the data creates a more uniform background of relative 
abundance for the yeast proteins in the sample but it also alters the reported abundance of 
the UPS proteins, which is likely to lead to artificial differences between replicates.  As such, 
a specialised normalisation scheme was designed to correct independently for global 
differences in UPS and yeast protein abundance within replicates. 
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Figure 16: Box plots of log ratios for the UPS1 proteins identified in each comparison by all pipelines, for both raw 
and normalised data.  
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Figure 17: Box plots of log ratios for the yeast background proteins identified in each comparison by all pipelines, 
for both raw and normalised data.  
Katherine I Mackay 
  56 
2.4.3 - Consensus across different tools 
 
Next an assessment was made to evaluate the sensitivity of the different software packages 
for evaluating differential expression of proteins and the FDR associated with a given 
sensitivity value, and to study the effect of using different pipelines in a combined approach 
as a strategy to improve sensitivity while simultaneously lowering the associated FDR. 
 
2.4.3.1 - Measurement of differential expression by Student’s t-test 
Two-tailed t-tests were performed to calculate p-values from the complete set of CPTAC 
results for the three comparisons being studied (E/B, E/C and E/D), as analysed using each of 
the four software packages (two versions of the results obtained from Progenesis LC-MS are 
included to highlight the effect of changing the identification threshold).  The null hypothesis 
is that a given protein is not changed in abundance, with the alternative hypothesis being 
that there is differential expression between different conditions. 
 
2.4.3.2 - Pseudo-ROC Plots 
A p-value was calculated for every protein and the results table ordered by p-value for each 
software package and for each comparison.  It was possible to estimate an FDR value 
associated with every p-value, via the count of differentially expressed UPS proteins (true 
positives) versus differentially expressed yeast proteins (false positives).  The FDR values 
were then converted to q-values and line graphs plotted of the sensitivity (proportion of the 
48 proteins scored as differentially expressed for each q-value) to create pseudo-ROC plots.  
The ROC plots show (see Figure 18) that for all pipelines the use of p-values assigns many 
yeast proteins as significantly differentially expressed, and therefore a high FDR is necessary 
to achieve a reasonable sensitivity. 
 
The E/B comparison should be the comparison in which it is easiest for the packages to 
achieve high sensitivity and low FDR, yet values of ~30-90% FDR are observed in order to 
achieve 50% sensitivity.  For the E/C comparison values of ~40-90% FDR are observed at 50% 
sensitivity, and for E/D, the most difficult comparison for packages to find differentially 
expressed proteins in correctly, FDR values of 25% to 80% are observed at 50% sensitivity.  
In all cases, in order to achieve high sensitivity (say 80%) - FDR values of ~80-90% occur, 
which would clearly be problematic in any real biological study where the ground truth is 
unknown.  Figure 18 is also annotated with the value of sensitivity and q-value that would 
Katherine I Mackay 
  57 
be obtained when a (typical) threshold of p<0.05 is set.  In all cases the performance is 
unacceptably bad – generally leading to FDR > 80%.  However, the intensity based methods 
far out-perform the spectral count methods using this statistical test.  Within Progenesis LC-
MS two import thresholds were used when loading identifications from Mascot, a lower, 
arbitrary threshold and a higher threshold based on the confidence value given by Mascot.  
It is seen that the maximum possible sensitivity is decreased when using the higher threshold 
for loading identifications (see Figure 18, upper three panels – the yellow line represents the 
lower threshold and the green line represents the higher threshold) - this is an example of 
the importance of setting this threshold correctly as it shows that setting too high a threshold 
can mean that true positives are missed.  The effect of changing the import thresholds will 
be considered in more depth below (see Chapter 4, page 98).  It is clear that for this study at 
least, using a t-test to compute p-values is not appropriate.  In each study condition, there 
are only three replicates and it appears that there is too much background variability 
between replicates to achieve accurate p-values using this method. 
 
A parallel analysis was completed with the protein results ordered by fold change, with the 
fold change being calculated for every protein and the results table re-ordered by these fold 
change values for each software package and for each comparison.  Again, an FDR was 
estimated for every fold change value, via the count of differentially expressed UPS proteins 
(true positives) versus differentially expressed yeast proteins (false positives).  The FDR 
values were then converted to q-values and line graphs plotted of the sensitivity (proportion 
of the 48 proteins scored as differentially expressed for each q-value) to create pseudo-ROC 
plots.  In the E/B comparison, ordering by fold change leads to an improvement in the 
sensitivity to FDR relationship for all packages. This is not unexpected since the UPS proteins 
on average are present in a 27:1 ratio, compared to the yeast proteins that are expected to 
be present at a 1:1 ratio.  In the E/C and E/D comparisons, the performance of all packages 
gets progressively worse as the differentially expressed UPS proteins become harder to 
distinguish from the yeast background.  However, Progenesis LC-MS and MaxQuant appear 
roughly comparable when the lower identification threshold (i.e. fewer weak identifications 
are allowed) is used to import identification results into Progenesis LC-MS. 
 
Annotations have been added to the figures to show the FDR and sensitivity values that 
would result if a “2 fold threshold” were applied to each pipeline, as this is a threshold that 
has commonly been used in published studies. There is clearly great variability in all 
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comparisons and in no pipeline does the use of a 2 fold threshold accurately control FDR and 
achieve a reasonable level of sensitivity.  As such, in order to achieve good sensitivity and 
low FDR for this data set, an optimised fold-change threshold would need to be applied 
individually for each comparison.  Clearly in a real data set, where the true ratios of the 
proteins are unknown, the level of these thresholds would be challenging to assess. 
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Figure 18: Pseudo-ROC plots for all comparisons ordered by p-value and fold change, annotated with p-value = 0.05 and fold change = 2.  Key: Blue line = emPAI, Red line = APEX, Green line = 
Progenesis LC-MS intensity values (higher threshold), Yellow line = Progenesis LC-MS intensity values (lower threshold), Black line = MaxQuant. 
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2.4.3.3 – CPTAC Heatmaps 
A way to visually assess the consensus across pipelines is to create a heatmap for each of the 
three comparisons, with dendrograms calculated both for the protein axis and the software 
axis based on distance.  The results from the E/B comparison are shown in Figure 19.  Only 
one cluster of proteins show any clear pattern to the results from all software pipelines - at 
the top of the heat map.  This cluster contains: 42 ups proteins and 29 yeast proteins, giving 
an FDR of 41% and a sensitivity of 88%.  No UPS1 proteins are identified outside of this 
cluster, giving the heatmap method a significant performance gain over the best individual 
package in terms of identifying differential expression.  For the other comparisons; the heat 
map for the E/C comparison has a clear differentiated cluster with an FDR of 24% and a 
sensitivity of 92% and that for the E/D heatmap cluster had an FDR of 23% and a sensitivity 
of 90%. 
 
These all show significant improvements over the use of any single package and have the 
advantage that they do not rely on arbitrary p-value or fold change thresholds.  Clearly, there 
is still a substantial FDR with all methods, however there are genuine differences in some 
yeast proteins in some replicates i.e. it is likely that many of the 29 yeast proteins that cluster 
on the E/B heatmap are genuinely differentially expressed.  In each of the four columns on 
the heatmap, each individual package finds many other proteins as changing in abundance 
(any strong green or red signal), but almost none of these are UPS1 proteins, and with almost 
no agreement with other software packages, implying that the difference is due to the way 
in which the software has processed the data rather than any underlying feature of the data 
set itself. 
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Figure 19: Heatmap (E/B comparison) comparing data from all pipelines, with zoom section of the top cluster of 
upregulated proteins including the UPS proteins 
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2.4.3.4 - QPROT post-processing 
In an attempt to determine differential expression more accurately, the QPROT tool was 
used to create an additional set of ROC plots (see Figure 20).  In general, QPROT is able to 
determine differential expression for all packages more accurately than either pair-wise t-
tests or fold change measurements.  In the E/B and E/C comparisons, MaxQuant 
performance appears to be best and there is a marked improvement in the emPAI curve, 
rendering it comparable to the intensity based methods for the E/B and E/C comparisons.  
When the ratios are smaller (in the E/D comparison) the plot shows that Progenesis LC-MS 
considerably outperforms the other pipelines when used with the lower identification 
threshold.  In the E/D comparison, all packages perform better with QPROT post-processing 
than by fold change or t-test, but no package is able to detect more than 80% of the UPS 
proteins without incurring a substantial FDR (25-80%).  Across all conditions the APEX tool 
appears to perform less well than emPAI.  However, it should be noted that the emPAI 
method is considerably simpler to apply to spectral count data.  In contrast, obtaining APEX 
values requires a number of processing steps through different tools, which may not have 
been optimised in this analysis.  Given that the underlying basis of APEX and emPAI are 
broadly similar, it would be expected that APEX performance should be comparable to emPAI 
and though it is likely that each of the processing steps could be optimised to bring the 
experimental values closer to the ground truth the optimisation required would be unique 
to each dataset.  Clearly then, it would not be possible to ascertain the optimal parameters 
when the ground truth was not know, i.e. with a real experimental dataset.  An interesting 
question for further work may be to assess the success of analysis of carefully prepared 
standard known datasets following optimisation with a similar standard dataset.  There are 
issues however with whether such a method would be transferable to the experimental 
laboratory, as the design of a standard dataset that is suitably similar to experimental 
samples would be highly challenging. 
 
As illustrated in the previous section, there is currently no universal statistical test and 
threshold that can control FDR in the analysis of this data set.  Our hypothesis is that if 
different software pipelines agree on a result i.e. that a protein is changing in abundance; 
this gives greater confidence that this interpretation is correct, since different pipelines are 
likely to make different kinds of errors.  Figure 20 displays the result from a new method 
which can be used to find consensus between different packages, in terms of those proteins 
which are called as differentially expressed.  In this method, the absolute mean Z-statistic is 
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calculated from the Z-statistic values given by the QPROT tool for each of the four pipelines 
studied.  In comparisons E/B and E/C, excellent performance is observed, far outperforming 
any individual software package, even when that packages results have been post-processed 
with the QPROT tool, achieving around 90% sensitivity before any false positives are 
incurred.  The E/D comparison also shows a considerable performance gain over any 
individual package, for example, achieving more than 80% sensitivity with less than 10% FDR 
compared with the best individual package having approximately 25% FDR for the same 
sensitivity.  As an example of why the consensus method is successful, the yeast protein 
YDR334W is measured as strongly differentially expressed by Progenesis LC-MS in the output 
from the QPROT tool (second ranking protein overall), with a Z-statistic of 3.49 in the E/D 
comparison.  The other three packages have no value for this protein, meaning it has 
presumably been misidentified or is present at low abundance, leading to a mean z-statistic 
of 0.87.  Several other yeast proteins share this profile, indicating that the consensus method 
is acting as a filter for low-quality or low abundance data.  A possible explanation for this 
misidentification within Progenesis LC-MS is that once a protein has been assigned from one 
spectra it will be inferred to be present in other spectra even if there is no discernible peak 
and no identification data is present i.e. when no MS-MS spectra have been recorded.  A 
different type of example is the yeast protein YPL154C, scored as strongly differentially 
expressed by Progenesis LC-MS in the E/D comparison (Z: 2.66), but with Z values from other 
packages as 0.14 (MaxQuant), 0.51 (emPAI) and 0 (APEX), leading to abs. mean Z = 0.83. In 
the E/D comparison, there is agreement between Progenesis LC-MS and MaxQuant on two 
yeast proteins that are strongly differentially expressed - YNL208W and YMR058W, but again 
with much reduced Z values from the spectral count methods - YNL208W 2.01, 2.94, 0.76 
and 0; YMR058W 2.13, 2.74, 0 and 0 (from Progenesis LC-MS, Maxquant, emPAI and APEX 
respectively). 
 
A further aspect to consider for the consensus method is the setting of appropriate 
thresholds.  On Figure 20 the point corresponding with abs. mean z > 1.96 is also annotated, 
which would be approximately analogous to p <0.05 in a two-tailed t-test.  For the E/D and 
E/C comparisons, this appears to be an appropriate threshold for separating the false 
positives from true positives.  In the E/D comparison however, this threshold is too 
conservative, reporting FDR = 0 but a sensitivity value of only 0.25. 
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It is clearly a labour intensive task to run four packages on the same data set.  As such, the 
use of different combinations of software packages was studied to assess whether the same 
performance gains can be achieved using fewer software packages.  The combinations 
assessed were: MaxQuant, Progenesis and emPAI; MaxQuant and Progenesis; MaxQuant 
and emPAI; and Progenesis and emPAI.  The pseudo-ROC plot profiles (shown in Figure 21) 
for the E/B and E/C comparisons are relatively similar for all combinations, showing that 
using an intensity-based package in combination with at least one other package (intensity 
or spectral counting based) is sufficient to accurately detect differential expression.  In the 
E/D comparison, the performance of most combinations is similar, with a slight drop in 
performance for MaxQuant and emPAI, presumably since Progenesis LC-MS was the best 
performing individual package in this comparison and for this dataset.   
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Figure 20: Pseudo-ROC plots for all comparisons ordered by QPROT FDR, annotated with QPROT FDR < 0.05 and QPROT Z-stat > 1.9.  Key: Blue line = emPAI, Red line = APEX, Green line = 
Progenesis LC-MS intensity values (higher threshold), Yellow line = Progenesis LC-MS intensity values (lower threshold), Black line = MaxQuant, Grey line = Combined QPROT (by mean Z-stat). 
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Figure 21: Pseudo-ROC plots for all comparisons ordered by QPROT Z-statistic using multiple packages combined in a consensus method.  Key: Blue line = Progesis and MaxQuant, Red line = 
Progenesis, MaxQuant and emPAI, Green line = Progenesis and emPAI, Grey line =  All four pipelines (Progenesis, MaxQuant, emPAI and APEX).
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2.5 - Discussion and Conclusions 
 
Many different software packages are available to post-process label-free proteomics data 
and obtain quantitative values, and there are also several reported methodologies that can 
also be used independently or alongside these software packages.  In this study a single 
dataset was analysed using four different software packages and the results of these 
analyses were then compared and post-processing options explored to assess the value of 
using a combination of software packages to analyse quantitative label-free proteomics data. 
 
The dataset used in this study was created for use in CPTAC Study 6, which required a 
standard sample of known protein concentrations against a complex background.  To achieve 
this a standard protein mix (UPS1) was spiked into a yeast background sample at several 
concentrations.  In the study presented above ratios were calculated between conditions 
and compared to the known ratios which should have been present.  The two intensity based 
methods (MaxQuant and Progenesis LC-MS) most closely report the correct UPS1 protein 
ratios when the raw protein abundance values are used, indicating that the spike-in had been 
done correctly.  However it was observed that applying global normalisation to the data 
skewed the UPS1 protein ratios – suppressing the ratios in Progenesis LC-MS and increasing 
the ratios in MaxQuant.  This is concluded to be because though the majority of the proteins 
in the sample are expected to be present at a 1:1 ratio, when one replicate is chosen as the 
master some replicates show global differences in the abundance of yeast proteins relative 
to this master.  Global normalisation brings these differences into line, however it also 
changes the values for the UPS proteins.  This means that the presence of multiple 
distributions should be considered when there are multiple populations present in a sample 
and it would be ideal to apply specifically tailored normalisation schemes to those datasets 
i.e. performing normalisation to each distribution separately.  Evidently this type of strategy 
requires an in depth knowledge of the dataset that is being studied, which is potentially 
challenging when studying real biological data.  Another consideration which arose from the 
study of this dataset is the necessity to ensure that the background proteins present in a 
standard protein mix are truly homogenous over all samples, as in this dataset there were a 
lot of yeast proteins which were identified to be changing between conditions/replicates (as 
the ratios for the UPS proteins were broadly correct, this lends confidence to the conclusion 
that there is true variation in the majority of the yeast proteins reported as changing in 
abundance). 
Katherine I Mackay 
  68 
 
It was seen that p-value and fold change thresholds were ineffective as a method to increase 
sensitivity and reduce FDR, with a high FDR being necessary to achieve 80% sensitivity.    This 
is more pronounced in the spectral counting based data where an 80-90% FDR is present, 
while the intensity based methods achieve both increased sensitivity and decreased FDR.  
While it could be possible to optimise thresholds for a known dataset, this is not possible in 
a real dataset where the ground truth is unknown.  The use of the QPROT tool renders all the 
techniques more effective in terms of increasing sensitivity while reducing FDR, and indeed 
this post processing provides enough improvement to the emPAI data in particular to render 
it comparable to the intensity based methods.  It was observed that p-value calculations are 
particularly unsuited to label-free data where there is high variability between replicates, 
particularly when the number of replicates is low.  Fold change and p-value should be weakly 
correlated, however as p-value calculations take the variance between replicates into 
account and fold change calculations do not, the level of correlation will be dependent upon 
the present variation across replicates in the given dataset. 
 
Two methods were used to assess the benefit of using multiple packages in conjunction to 
achieve a consensus result.  The first method concerned the generation of heatmaps, which 
are a useful technique to get a visual representation of a consensus on differential expression 
in the data.  Despite this there is still a large FDR associated with a reasonable level of 
sensitivity.  The second consensus method uses the results output by the QPROT tool, 
specifically using a mean absolute Z-statistic calculated for each protein from the Z-statistic 
values output by QPROT for each software pipeline.  This value was used to produce pseudo-
ROC plots with a greatly improved FDR to sensitivity ratio – giving approximately 90% 
sensitivity before false positives appear in the results list.  The main advantage of this method 
is that it is unlikely that a false positive protein will be identified with a high Z-statistic value 
by all software pipelines and therefore the effect is that the false positive proteins are filtered 
out from the results. 
 
In conclusion there is a definite benefit to using multiple software packages to achieve a 
consensus result.  Even when only two software packages are used in conjunction with the 
QPROT tool there is a significant improvement in the sensitivity to FDR ratio.  This is a realistic 
way to conduct studies, which could be utilised by study groups working on real biological 
data, especially as emPAI numbers are reported directly from Mascot, which is very widely 
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used.  The emPAI can then be used in conjunction with the intensity based package of choice 
to give a consensus on which proteins are truly differentially expressed. 
 
As an extension to this study it would be extremely useful to obtain or design samples such 
that they contain known amounts of several proteins or groups of proteins, in order that the 
ground truth is known.  Such a dataset was designed by Stefan Tenzer, and presented at 
various conferences, which contains weighted populations of mouse, yeast and E-coli 
proteins to ensure a uniform total protein amount.  Work on this or other similar datasets 
could also further consider the merits of splitting the experimental data into its constituent 
data distributions prior to normalisation steps. 
 
In addition to the considerations outlined above, the work for this study was completed in 
2009-2011, and it is possible that the results could be improved were the analysis repeated 
using modern search engines (such as Byonic[105, 106], PEAKS[107, 108] or ProteinPilot (AB 
Sciex)) for the protein identification step. 
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3 - Pairwise comparisons of the results obtained when using 
different mass spectrometry instrument platforms for label-
free data 
 
3.1 - Introduction 
 
The recent increased popularity of label-free proteomics has been mirrored by an increase 
in the number of mass spectrometry instruments which are suitable for that purpose.  These 
instruments are often from different instrument vendors, and have a variety of different 
mass analysers, ion optics, or combinations of mass analyser types. 
 
Each laboratory performs biological experiments using the instrumentation that they have 
available, or which they have chosen (from a small or wide range of options) as most 
appropriate for a given experiment, and the reported results are considered comparable by 
the proteomics community.  This study was designed to test this assumption of comparability 
between instrument platforms by assessing the correlation between the results obtained 
when the same biological samples were run on two different mass spectrometers, and post 
processed analogously (using Non-linear Dynamics’ Progenesis LC-MS and self-written Java 
code).  An ideal dataset would come from an experiment in which identical chromatographic 
conditions had been used on both instruments, however this dataset was obtained using the 
standard chromatographic conditions for both instruments (the chromatographic conditions 
used are shown below in Table 3).  While this is not ideal, it may represent a more accurate 
representation of the typical situation where samples are sent to be analysed on multiple 
instruments or where the mass spectrometric analysis is conducted by a non-expert user 
with the “standard” instrument parameters. 
 
The two mass spectrometers used in this study were a Thermo Scientific Orbitrap VELOS and 
a Waters Synapt G2.  These are both popular instruments from well-respected vendors, but 
they possess very different internal ion optics, as detailed below and shown in Figure 22. 
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Thermo Scientific Orbirtrap VELOS: This is an orbitrap instrument in which ions pass through 
a linear ion trap to a curved linear ion trap (C-trap) and can then be sent to the orbitrap or 
onwards to the collision cell.  There is capability within the ion optics to analyse both parent 
and fragment ions using the orbitrap.  Initial mass analysis and ion selection is generally 
performed in the orbitrap, with the ions then being passed through the C-trap and collision 
cell to a linear ion trap for fragmentation, or passed straight to the scanning electron 
microscope (SEM) detector.  In this experiment the instrument was set up to perform data 
dependent analysis on the twenty most intense ions in each full MS scan, which are passed 
sequentially into the collision cell for fragmentation after ion selection and accumulation. 
 
Waters Synapt G2: This is a time-of-flight instrument with an electrical W-shaped flight path 
within the flight tube, achieved by two ion mirrors.  This allows increased resolution in the 
mass measurements via increasing the length of the ion flight path without an analogous 
increase in the physical length of the flight tube itself.  The ions pass through an initial 
quadrupole stage and then into a helium cell where, uniquely for this instrument, all ions are 
fragmented as the instrument switches at high speed between high and low collision 
energies throughout the experiment.  The advantage of this is that there is MS-MS 
information for every ion observed in the full scan spectrum, whereas data dependent 
analysis only provides information about the most intense ions.  This unique method of 
analysis is marketed by Waters as MSE and is more generally referred to as data independent 
acquisition (DIA). 
 
 Orbitrap SYNAPT 
Column nanoACQUITY UPLCTM 
BEH130 C18 15cm x 75µm, 
1.7µm capillary column 
nanoACQUITY UPLC HSS T3 
C18; 15cm× 75μm, 1.7μm 
capillary column 
Gradient 3-40% acetonitrile in 0.1% 
formic acid for 90min then 
40-85% acetonitrile in 0.1% 
formic acid for 3 min 
3-40% acetonitrile in 0.1% 
formic acid for 120 min 
Flow Rate (nl/min) 300 300 
Table 3: Chromatographic conditions for the mass spectrometric analysis on each instrument
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Figure 22: Schematic diagrams showing the internal optics of both the Thermo Scientific Orbitrap VELOS and the Waters Synapt G2, taken from the SYNAPT G2-S HDMS Operator’s Overview 
and Maintenance Guide and the Thermo Scientific LTQ Orbitrap Velos Product Specifications respectively
 
 
a 
b 
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3.2 - Methods 
 
Time-course data was collected from a culture of human foreskin fibroblast cells infected 
with Toxoplasma gondii VEG (data collected at 2, 4, 8 and 16 hours post infection, data from 
2, 4 and 8 hours post infection used for this study).  Three biological samples were collected 
for each timepoint and the sample preparation was completed analogously.  Each sample 
was then run on the two instruments using their respective routinely used optimised 
chromatographic conditions and comparable analytical columns (C18 15cm x 75µm, 1.7µm 
capillary column, 300nl/min flow rate, 35⁰C, gradient: 90mins 3-40%B, 3mins 40-95%B and 
120mins 3-40%B for the Thermo Orbitrap VELOS and the Waters Synapt G2 respectively).  
The wet-lab work was completed by a collaborator (Dr Dong Xia), and the raw data output 
from the mass spectrometry analysis was obtained and used for this study.  Post-processing 
was completed using Progenesis LC-MS, as comparatively as possible, with only a slight 
divergence in the methods used.  This was due to the fact that only the specifically designed 
Waters software (ProteinLynx Global Server or PLGS) is capable of processing the MSE data 
from the Waters Synapt G2 instrument.  PLGS was therefore used to perform database 
searching of the MSE data, using a reverse database generated within PLGS itself.  The results 
of this analysis were then exported using the Progenesis PLGS plug-in and the output 
imported into Progenesis LC-MS for further analysis.  PLGS is vendor software from Waters 
and therefore cannot be used to process data from instruments sold by other vendors i.e. 
the raw data obtained for this study from the Thermo Scientific Orbitrap VELOS.  Therefore 
this data was aligned in Progenesis LC-MS to create a merge file representing the aggregate 
spectrum, which was then searched against the reverse database generated by PLGS using 
Mascot (Matrix Science) on the in-house Mascot server.  The Mascot result file (as an XML) 
was then imported back into Progenesis LC-MS to complete the parallel analyses. 
 
Once the analysis in Progenesis LC-MS was complete the feature level data was exported as 
.csv files for further analysis.  The exported feature list files were input into self-written Java 
code which finds the common peptide sequences and reads out the data from both 
instruments into a single file (peptide sequence, feature ID, modifications, peptide score and 
abundance values are included in this file), referred to as the common features file. 
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The common features file and the feature list files from both instruments were then saved 
as Excel workbooks for manual/semi-automated analysis.  For the feature level analysis score 
(10%, 25% and 50% percentiles, i.e. retaining the top 10, 25 or 50% of the data respectively) 
and abundance (25% and 50% percentiles) thresholds were applied to the common features 
file and the resultant data saved as separate .csv files containing the abundance data for 
each time point studied.  These were used as input for self-written R code which produces a 
correlation plot of the data. 
 
For the protein level analysis the common features file was saved as an Excel workbook and 
that data copied into several duplicate sheets, to which a threshold was applied by either 
score (again using 10%, 25% and 50% percentiles, i.e. retaining the top 10, 25 or 50% of the 
data respectively) or abundance values (again using 25% and 50% percentiles) using the 
PERCENTILE function built into Excel.  Those features which passed the relevant thresholds 
were then moved to separate sheets to be used for reference.  A  VLOOKUP function was 
used to search between the Progenesis LC-MS feature list workbooks and the reference 
sheets in the common features workbook, this imported the data if it passed a given 
threshold and otherwise reports a blank row.  This gave sheets which were in the same 
format as the original Progenesis LC-MS output but contained only the features which passed 
the relevant thresholds (the formula reported non-passing features as blank rows, which 
were then deleted by filtering for blanks and deleting the matching rows).  An additional step 
was required because there are duplicate features assigned to some of the peptide 
sequences (usually when different charge states had been assigned to the same peptide) in 
both datasets.  To remove the duplicates the data was sorted alphabetically by peptide 
sequence and then by the abundance of the relevant replicate (or by the score for the score 
thresholded data).  The second level of the search was to ensure that the most abundant (or 
highest scored) peptide was taken forward through the analysis when the remove duplicates 
function was used (this function retains the first instance of a duplicate and removes 
subsequent instances).  Before further processing the file was then sorted by number to get 
the list back into the order as it was reported in the original Progenesis LC-MS output file. 
 
The thresholded feature list files were also input into the Progenesis Post Processor (PPP) 
software which was written in-house by Dr Da Qi[109].  This package uses the feature data 
to produce hi3 protein data (from the top three features assigned to each protein i.e. the 
three assigned features which have the highest ion abundance) which is analogous to that 
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produced by PLGS for the Waters MSE data, and also produces total abundance protein data.  
It was these protein results from the PPP that were used in this study for further protein level 
analysis. 
 
The protein results from the PPP were edited manually in Excel to create a file with the same 
headings as a Progenesis LC-MS output file.  This could then be input into the self-written 
Java code to find which proteins were common between the two instruments and read these 
out into a new file called the common proteins file.  This file was used to generate .csv files 
containing the data for each time point studied, and these were used as input to R code 
written to produce correlation plots of the data.
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Figure 23: Flowchart describing the process from .raw data to the final correlation plots 
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3.3 - Results 
 
3.3.1 - Common and unique proteins 
 
The first and most basic exploration of the data was a simple comparison of the number of 
proteins identified following analysis of the data from each instrument.  The numbers for the 
unique proteins were taken from the original Progenesis LC-MS output files, while the 
number of common proteins was taken from the common proteins report file generated by 
my Java code with these output files as the input.  It was decided to use these files for this 
part of the analysis to remove any bias introduced by forcing the use of common features 
only for protein inference (as is done in the later analysis when only common 
features/proteins are considered). 
 
Figure 24 shows that approximately one fifth of the proteins (339 out of 1453) identified in 
the Thermo Orbitrap VELOS data were common to the result sets generated by both 
instruments, compared to just under half of the proteins identified in the Waters Synapt G2 
data (339 out of 381).  This translates to a quarter and two thirds respectively when a three 
peptide threshold is applied. 
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Figure 24: Venn diagrams showing the number of proteins reported by both instruments, with the number of 
common proteins also shown.  Top shows all the reported proteins, while the lower Venn shows the resultant 
data when a three peptide threshold is applied. 
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3.3.2 - Pearson correlation 
 
It is essential to accept the assumption that the results obtained from running a single sample 
on different instruments should give correlated results to allow the comparison of 
conclusions drawn by different groups about the differential expression of a protein of 
interest.  By producing Pearson correlation plots of the data obtained in this study the 
assumption of correlation was tested for both hi3 and total abundance data (from PPP 
output), and following the application of score and abundance thresholds to both. 
 
3.3.2.1 - Feature data correlation at different thresholds 
 
The feature data from both instruments is observed to correlate reasonably well – with 
Pearson values between 0.5 and 0.9 (see Table 4).  The application of score thresholds (i.e. 
retaining the top 10, 25 or 50% of the data when ordered by peptide score) yields 
unpredictable results in the feature data.  A higher score threshold would be expected to 
increase the correlation between the two instruments, however an increased score 
threshold is observed to cause both increased and decreased correlation depending on the 
time point being studied (see Table 4, left hand panels). 
 
The effect of abundance thresholds is more as expected, i.e. the data shows a positive trend 
in Pearson value as the threshold is increased.  At all time points there is a large jump in the 
Pearson value following the application of a 25% abundance threshold (with respect to no 
threshold being applied), and a smaller increase when a 50% threshold is applied (see Table 
4, right hand panels).  It can also be seen from the correlation plots that it tends to be low 
abundance features which are identified by only one of the two instruments. 
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Sample 1.1 
      
Threshold 
Score 
Correlation Abundance Correlation 
None 0.5598 0.5598 
10% 0.5736 n/a 
25% 0.4492 0.7492 
50% 0.3941 0.8367 
Sample 2.1 
      
Threshold 
Score 
Correlation Abundance Correlation 
None 0.5934 0.5934 
10% 0.6068 n/a 
25% 0.606 0.8061 
50% 0.707 0.8957 
Sample 3.1 
      
Threshold 
Score 
Correlation Abundance Correlation 
None 0.578 0.578 
10% 0.5867 n/a 
25% 0.5683 0.7689 
50% 0.6791 0.8491 
Table 4: Pearson value tables for Orbitrap vs Synapt (feature level) data at all timepoints.  “Score Correlation” 
refers to the Pearson value observed when thresholds are applied at 10, 25 and 50% percentiles respectively, to 
the data when ordered by peptide score.  “Abundance Correlation” refers to the Pearson value observed when 
thresholds are applied at 10, 25 and 50% percentiles respectively, to the data when ordered by peptide 
abundance.
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Figure 25: Correlation graph for Orbitrap vs Synapt (feature level) data at 50% abundance threshold for Sample 1.1 
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3.3.2.2 - Protein data correlation at different thresholds 
 
In general the protein data shows improved correlation between instruments with respect 
to the feature data (where the Pearson values ranged from 0.5-0.9, see Table 4), as all but 
one Pearson value being above 0.9 and that one value still being high at 0.8573 (see Table 
5).  This is considered to be as expected because each feature assigned to a protein 
contributes to the final protein abundance, and thus the effect of those features which have 
low abundance and high variability will be somewhat masked at the protein level. 
 
The application of peptide score thresholds is again observed to have no reliable influence 
on the correlation of the two sets of data, with the Pearson value being above 0.9 at all 
thresholds (see Table 5, left hand panels).  However the application of score thresholds does 
markedly affect the number of proteins identified – a 50% score threshold reduces the total 
number of commonly identified proteins from 96 to 16 (14 for hi3 data where NaN values 
were removed – these arise where the protein has been identified and reported within the 
total abundance data from Progenesis LC-MS but does not have three or more peptides and 
therefore does has no reported hi3 abundance values).  This large reduction in the number 
of proteins identified is a trade-off that few would be willing to accept, especially there is no 
reliable improvement seen in the Pearson values (see Table 5, left hand panels). 
 
The application of abundance thresholds shows more of an effect to the correlation between 
the two datasets, with the greatest improvement being seen in the total abundance data 
where an improvement of 0.02 has been observed in the reported Pearson value when a 
50% abundance threshold has been applied. 
 
As a general observation it is seen that there is greater correlation in the hi3 data than in the 
total abundance data (see Tables 5-7 below).  One possible explanation for this is that the 
hi3 process excludes those lower abundance peptides which are more likely to be recorded 
unpredictably due to differences in ionisation efficiency and ion transfer through the ion 
optics of the different instruments. Those peptides which are more readily ionised will be 
present at greater abundance within the mass spectrometer and therefore transfer 
differences between instruments will have a proportionally lower effect on high abundance 
ions and thus greater correlation is to be expected for these ions. 
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The application of abundance thresholds has a less extreme effect on the number of 
identified proteins than the application of score thresholds, however the reduction in 
number is still quite large, with a 50% threshold reducing the protein count to 38 from 98. 
 
Protein Correlation – Sample 1.1 
              
Score Values   Abundance Values 
              
hi3       hi3     
Threshold Pearson No. of Proteins   Threshold Pearson No. of Proteins 
None 0.9696 96   None 0.9635 98 
10% 0.9713 82   25% 0.9714 69 
25% 0.9223 59   50% 0.9736 38 
50% 0.9755 14         
              
              
Total Abundance   Total Abundance 
Threshold Pearson No. of Proteins   Threshold Pearson No. of Proteins 
None 0.9554 96   None 0.9516 98 
10% 0.9329 82   25% 0.9587 69 
25% 0.9182 59   50% 0.9654 38 
50% 0.8573 16         
Table 5:  Protein correlation values for hi3 and total abundance data, for the first time point with score and 
abundance thresholds applied.  “Score Values” refers to the Pearson value observed when thresholds are applied 
at 10, 25 and 50% percentiles respectively, to the data when ordered by peptide score.  “Abundance Values” 
refers to the Pearson value observed when thresholds are applied at 10, 25 and 50% percentiles respectively, to 
the data when ordered by peptide abundance.  The upper panels show values for the  hi3 data, while the lower 
panels show the values for total abundance data. 
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Protein Correlation – Sample 2.1 
              
Score Values   Abundance Values 
              
hi3       hi3     
Threshold Pearson No. of Proteins   Threshold Pearson No. of Proteins 
None 0.7943 96   None 0.7981 99 
10% 0.7983 82   25% 0.9594 61 
25% 0.9261 59   50% 0.9797 35 
50% 0.9563 14         
              
              
Total Abundance   Total Abundance 
Threshold Pearson No. of Proteins   Threshold Pearson No. of Proteins 
None 0.9244 96   None 0.927 99 
10% 0.9273 82   25% 0.9474 61 
25% 0.8788 59   50% 0.9717 35 
50% 0.9548 16         
Table 6: Protein correlation values for hi3 and total abundance data, for the second time point with score and 
abundance thresholds applied.  “Score Values” refers to the Pearson value observed when thresholds are applied 
at 10, 25 and 50% percentiles respectively, to the data when ordered by peptide score.  “Abundance Values” 
refers to the Pearson value observed when thresholds are applied at 10, 25 and 50% percentiles respectively, to 
the data when ordered by peptide abundance.  The upper panels show values for the  hi3 data, while the lower 
panels show the values for total abundance data. 
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Protein Correlation – Sample 3.1 
              
Score Values   Abundance Values 
              
hi3       hi3     
Threshold Pearson No. of Proteins   Threshold Pearson No. of Proteins 
None 0.8233 96   None 0.816 99 
10% 0.8472 82   25% 0.9778 71 
25% 0.9309 59   50% 0.9737 41 
50% 0.9391 14         
              
              
Total Abundance   Total Abundance 
Threshold Pearson No. of Proteins   Threshold Pearson No. of Proteins 
None 0.9165 96   None 0.9232 99 
10% 0.9145 82   25% 0.9658 71 
25% 0.9096 59   50% 0.9587 41 
50% 0.8891 16         
Table 7: Protein correlation values for hi3 and total abundance data, for the third time point with score and 
abundance thresholds applied.  “Score Values” refers to the Pearson value observed when thresholds are applied 
at 10, 25 and 50% percentiles respectively, to the data when ordered by peptide score.  “Abundance Values” 
refers to the Pearson value observed when thresholds are applied at 10, 25 and 50% percentiles respectively, to 
the data when ordered by peptide abundance.  The upper panels show values for the  hi3 data, while the lower 
panels show the values for total abundance data.
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Figure 26:  Correlation graphs for Orbitrap vs Synapt (protein level) data at the 50% abundance threshold for Sample 2.1.  The left hand panel shows hi3 data and the right hand panel shows 
total abundance data (both hi3 and total abundance (PPPTA) data taken from the output of the Progenesis Post Processor).
Orbitrap vs Synapt – hi3 data, Replicate 2.1, 0.5 abundance Threshold               Orbitrap vs Synapt – PPPTA data, Replicate 2.1, 0.5 abundance Threshold 
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3.3.3 - Coefficient of Variance 
 
3.3.3.1 - Feature data 
 
Another way to examine the data and to compare the performance of the two instruments 
is to look at the coefficient of variance across the three biological replicates studied at each 
time point.  Though these are biological rather than technical replicates any variation 
between them should be constant as for each numbered sample a single pellet was made up 
into two samples which were run in parallel on both instruments.  Therefore it is considered 
that any remaining variation should be instrument dependent. 
 
The coefficient of variance was calculated for three sets of data (see Table 8) – raw values 
from Progenesis, normalised values from Progenesis, and MAD normalised data (as used for 
the CPTAC dataset in Chapter 2 above).  In all cases the coefficient of variance calculated for 
the Waters Synapt G2 was greater than that for the Thermo Orbitrap VELOS, with the highest 
CoV ratio being over two. 
 
It is possible that this is purely a function of Progenesis LC-MS being better optimised for the 
analysis of Thermo data (for which it was originally designed), but the increased variance 
could also arise from the unique sampling method employed within the Waters Syanpt G2 
instrument.  It is likely that the analysis of Waters Synapt data will soon be fully integrated 
into Progenesis LC-MS, and this would allow a fuller analysis with identical post processing, 
to fully identify the source of this variation. 
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Progenesis LC-MS Raw Data 
              
Sample Name Average coefficient of variation Median coefficient of variance 
  Orbitrap Synapt S/O Orbitrap Synapt S/O 
Inf1 0.326985 0.514743 1.5742075 0.2622783 0.3111407 1.1862999 
Inf2 0.314077 0.38989978 1.2414147 0.2792001 0.2878652 1.0310355 
Inf3 0.247974 0.42565086 1.7165174 0.1972386 0.2680221 1.3588722 
Progenesis LC-MS Normalised Data 
              
Sample Name Average coefficient of variation Median coefficient of variance 
  Orbitrap Synapt S/O Orbitrap Synapt S/O 
Inf1 0.272694 0.51660522 1.8944527 0.2016511 0.310943 1.541985 
Inf2 0.245177 0.329698 1.3447361 0.1909607 0.2118725 1.1095083 
Inf3 0.252664 0.41805392 1.6545863 0.2054736 0.25448 1.2385045 
Median Normalised Data 
              
Sample Name Average coefficient of variation Median coefficient of variance 
  Orbitrap Synapt S/O Orbitrap Synapt S/O 
Inf1 0.246791 0.49869671 2.0207273 0.1673684 0.2858771 1.7080708 
Inf2 0.228554 0.32818808 1.43593 0.1731137 0.2074545 1.1983712 
Inf3 0.248414 0.41800993 1.6827134 0.1997049 0.2513774 1.2587442 
Table 8: Coefficient of variance tables for median normalised feature data from both instruments 
 
Box plots were created for the coefficient of variance at all time points (median normalised 
data shown in Figure 27), and show that there is greater spread in the Waters Synapt G2 
data, though the median values from both instruments are similar (there are several outliers 
present outside the whiskers of the box plots, this is considered to be an artefact of there 
being thousands of data points within the dataset and is not unusual). 
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Figure 27: Box plots showing the coefficient of variance for feature data at all time points as analysed on both instruments (median normalised data) 
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The increased spread in the Waters Synapt G2 data implies that there may be some bad data 
points present, which skew the mean values.  It may be possible to pick out these “bad” data 
points by manually examining the extracted ion chromatograms and excluding any features 
that look unreliable.  However, based on this data, it is not possible to exclude data 
processing as the source of the increased variation shown in the Waters Synapt G2 data.  It 
is anticipated that a truly parallel analysis of the data from different instruments will soon be 
possible using Progenesis LC-MS, and this would allow a more in depth investigation of the 
sources of variation. 
 
3.3.3.2 - Protein data 
 
The coefficient of variance analysis was repeated with the protein data, again looking at both 
the raw and normalised data reported from Progenesis LC-MS and the median normalised 
data (calculated manually in Excel from the raw data).  For this part of the analysis the protein 
data calculated from all the features found by each instrument was used instead of that 
calculated from the common features only, in order to avoid any bias that could be 
introduced by reducing the number of available features from which protein abundance is 
calculated. 
 
In the protein data the coefficient of variance is highly similar between the two instruments 
(see Table 9), with normalisation of the data both within Progenesis LC-MS and manually by 
median absolute deviation within Excel causing a decrease in the average coefficient of 
variance for both instruments.  However this affect is more pronounced in the Thermo 
Orbitrap VELOS data than the Waters Synapt G2 data, meaning that again the coefficient of 
variance is higher for the Waters Synapt G2 – with the highest ratio (Synapt CoV over 
Orbitrap CoV) being 1.5 for the first time point. 
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Progenesis LC-MS Raw Data 
              
Sample Average coefficient of variance Median coefficient of variance 
  Orbitrap Synapt S/O Orbitrap Synapt S/O 
T1 0.208066 0.224417 1.078585 0.192651 0.164244 0.852546 
T2 0.224619 0.231215 1.029368 0.225126 0.219493 0.974978 
T3 0.148038 0.196253 1.325693 0.12992 0.155992 1.200674 
Progenesis LC-MS Normalised Data 
              
Sample Average coefficient of variance Median coefficient of variance 
  Orbitrap Synapt S/O Orbitrap Synapt S/O 
T1 0.156016 0.238345 1.5276923 0.136791 0.206549 1.5099616 
T2 0.148264 0.175233 1.1818932 0.135648 0.144262 1.0635025 
T3 0.146347 0.195426 1.3353595 0.128381 0.155845 1.2139279 
Median Normalisation Data  
              
Sample Average coefficient of variance Median coefficient of variance 
  Orbitrap Synapt S/O Orbitrap Synapt S/O 
T1 0.136987 0.202409 1.477577 0.110148 0.143632 1.303986 
T2 0.140895 0.16998 1.206428 0.125881 0.134142 1.065628 
T3 0.145043 0.193383 1.333282 0.127887 0.155739 1.217781 
Table 9: Coefficient of variance tables for median normalised protein data from both instruments.  The “S/O” 
column shows the ratio of Synapt CoV/Orbitrap CoV. 
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The same is clear when the normalised data is represented as box plots for both instruments 
(see Figure 28).   Again the median values for coefficient of variance are similar in the data 
from both instruments, but the spread is greater in the data from the Waters Synapt G2. 
On creating box plots of the raw and normalised protein data from both instruments it is 
seen that though the median coefficient of variance is more comparable between 
instruments, it is clear that the normalisation has been effective for this data. 
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Figure 28: Box plots of coefficient of variance for median absolute deviation normalised protein data at all time points 
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Figure 29: Box plots of coefficient of variance for raw protein data at all time points 
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3.4 - Discussion and Conclusions 
 
This study was designed to investigate the correlation of the data obtained from the analysis 
of identical biological samples on two different mass spectrometry instruments.  Data from 
different instruments is often compared in the literature, if not directly, then in the form of 
the conclusions made based on that data.  However there are few studies which look at the 
direct comparison of results when biologically identical samples are run on different 
instruments.  Though the two instruments used in this study are both considered to be high 
accuracy, there is potential for variation due to instrumental differences.  The Waters Synapt 
G2 may be expected to give higher accuracy quantitation data as quantitation in time-of-
flight instruments is achieved via direct ion counting, rather than through a Fourier transform 
as in the Thermo Scientific Orbitrap VELOS.  However, quantitation accuracy is also improved 
through increasing the number of peptides observed, and an orbitrap gives increased 
sensitivity due to the ion trapping and accumulation stage prior to detection. 
 
These results show that, for these two instruments at least, the correlation between the 
results is high at the protein level, while it is somewhat lower at the feature level.  The 
application of score thresholds (i.e. retaining the top 10, 25 or 50% of the data when ordered 
by peptide score) is not observed to have a predictable effect on the correlation of the two 
datasets; however the application of abundance thresholds does show a favourable 
relationship between increased abundance thresholds and a higher Pearson value.  While 
the feature level correlation can be improved considerably by applying abundance 
thresholds, this is mitigated at the protein level due to the combination of several peptide 
features into each protein abundance measurement.  Therefore it is considered that based 
on what is seen in this dataset there is little benefit to setting thresholds at the peptide level, 
while it could be detrimental in terms of losing proteins at the next level because they no 
longer possess sufficient quantitation peptides to be retained following the application of 
peptide thresholds. 
 
The number of proteins identified by each instrument was also investigated, and it was seen 
that the Waters Synapt G2 identifies fewer proteins than the Thermo Orbitrap VELOS – 1792 
vs 720 proteins (2.49 times the number) and that the majority of these proteins are common 
to the two instruments.  These numbers are reduced for both instruments when a three 
peptide threshold is applied, to 679 vs 264 proteins for the Thermo Orbitrap VELOS and the 
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Waters Synapt G2 data respectively, but the ratio between the two instruments remains 
approximately the same (the number of peptides identified by the Thermo Orbitrap VELOS 
being 2.57 times greater than that for the Waters Synapt G2). 
 
The assessment of the coefficient of variance for both instruments at all time points shows 
a greater variance in the Waters Synapt G2 data, though the median values for the average 
coefficient of variance are comparable between the two instruments.  It was observed from 
the creation of box plots that normalisation has a favourable effect on the coefficient of 
variance observed for both instruments, and has a greater effect on the Thermo Orbitrap 
VELOS data. 
 
It is concluded that for this data at least, there is little benefit to the application of score 
thresholds at either the feature or the protein level due to the unpredictable effect of their 
application on the correlation between the data from the two instruments.  The most 
beneficial threshold to apply for this data seems to be a 25% abundance threshold at the 
protein level, which gives a positive effect on the correlation between instruments and a 
tolerable reduction in the number of identified proteins.  Median absolute deviation 
normalisation is seen to reduce the instrument dependent variation seen between the 
separate biological replicates studied for each time point, and is therefore recommended.  
Hi3 data is seen to yield a higher Pearson value than total abundance data suggesting that 
the hi3 method is preferable, at least for this data set. 
 
As future work it would be beneficial to design or acquire a dataset composed of more 
samples, which had been run on a greater variety of instruments with identical 
chromatographic conditions and with at least three technical replicates.  It would also be 
beneficial to use multiple spike ins at various protein concentrations (possibly as a protein 
mix spike in, or by using a weighted sample containing multiple protein populations such as 
that described earlier in this thesis), in order to make an assessment of accuracy and 
reproducibility between instruments where the ground truth is fully known.  Ideally this 
analysis would be completed using the most up-to-date instruments, for example using a 
Thermo Scientific Fusion (quadrupole-iontrap-orbitrap tribrid instrument) versus Waters 
SYNAPT G2si (TOF).  It would also be useful to conduct an analysis with identical 
chromatographic conditions, as it is likely that one set of the conditions used in this work is 
more suited to this particular sample and it is not possible to dismiss the use of different 
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chromatographic gradients as the source of some of the variation between instruments that 
was observed in this study.  However, though identical chromatographic conditions are ideal 
to create fully comparable results, it can be argued that the comparison as presented is more 
relevant to the field as biological conclusions compared in the literature will arise from the 
optimised conditions used in each individual laboratory.  While a difference in 
chromatographic conditions may impact peptide-level identifications, this effect should be 
mitigated when peptide data is taken up to the protein-level.  For those peptides which are 
identified, peptide quantitation should be broadly unaffected by any difference in the 
chromatographic conditions used. 
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4 - The effect of the identification thresholds used on the results 
obtained from label-free data 
 
4.1 - Introduction 
 
In the software comparison study reported above (Chapter Two, Page 36), it was seen that 
the use of different score thresholds (e.g. the protein score reported by Mascot) when 
importing identification results had a large effect on the final quantitative output from 
Progenesis LC-MS.  The study presented below is intended to extend this observation further 
and investigate the use of multiple peptide-level FDR thresholds applied to Mascot-derived-
search results.  It is also intended to briefly test the hypothesis that the use of multiple 
database search engines will improve the results of the analysis, through the use of Mascot, 
OMSSA and X!Tandem data post processed with Scaffold.  Scaffold is a protein inference 
viewing and validation software (ProteomeSoftware)[110] capable of accepting 
identification data from multiple search engines, and allowing multiple peptide and protein 
level thresholds to be applied within the user interface. 
 
4.2 - Methods 
 
This study was conducted using the CPTAC data files that have been analysed using 
Progenesis LC-MS as described above (Chapter Two, page 36), with the Mascot result file 
from that work being used for the Mascot section of the study presented herein. 
 
Firstly the effect of altering the protein identification thresholds used was assessed, with all 
thresholds set within the Mascot output .csv file (processed manually in Excel).  To do this, 
the data was sorted by Mascot score and a manual peptide FDR calculated based on the 
number of concatenated target-decoy accessions assigned (counting each reverse accession 
as a false positive and calculating the FDR from FDR = FP / FP + TP).  It was then possible to 
pick out the Mascot score that corresponded to the desired FDR threshold (0, 1, 5, 10 and 
20% FDR thresholds were used), and these Mascot score thresholds were then applied at the 
import stage to Progenesis LC-MS when importing the Mascot .xml results file.  This import 
stage and post processing was then repeated for each Mascot score threshold in order to 
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obtain output protein list files (containing quantitative protein abundance values) from 
Progenesis LC-MS which correspond to each of the above FDR thresholds. 
 
For the second part of this study result files were obtained that had been generated by 
searching the data with OMSSA and X!Tandem, using analogous search parameters to the 
Mascot search (allow 1 missed cleavage, fixed modifications: Carbamidomethyl (C), variable 
modifications: Oxidation (M), Peptide Tolerance: +/-10ppm, MS-MS tol. +/-0.6Da).  The 
Mascot, OMSSA and X!Tandem data files were then imported into Scaffold (Version 4, 
Proteome Software)[110] as three biosamples, and with the auto-parse option selected to 
import the .fasta database file.  Within Scaffold a low (5%) protein probability threshold was 
set, with the intention that any observed variation could then be assumed to arise from the 
changing the peptide FDR threshold.  This peptide FDR threshold was set at 0.1, 0.5, 1.0, 2.0 
and 5.0, and a result file exported for each threshold.  These spectrum report result files 
were then imported into Progenesis LC-MS.  A further analysis was also conducted using a 
1% peptide FDR threshold and varying the protein FDR as it was observed that this stringent 
peptide threshold is required to remove unreliable data from the results. 
 
No manual filters were applied while importing Scaffold result files to Progenesis LC-MS, as 
thresholds had already been applied to the search result files.  Protein list files were then 
exported for further analysis in Excel.  Protein abundance ratios were calculated for each 
comparison (E/B, E/C and E/D) and the lists ordered to filter the UPS1 proteins to the top of 
the sheet.  The ratio lists were then copied into new .csv files as input to in-house R code in 
order to generate box plots of the data. 
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4.3 - Results 
 
4.3.1 - Manual peptide FDR thresholds applied to data searched using Mascot 
 
Box plots showing abundance ratios for the UPS1 proteins in all comparisons (E/B, E/C and 
E/D) at five peptide FDR thresholds (0, 1, 5, 10 and 20% peptide FDR) are shown below in 
Figure 28.  The results from this analysis are interesting, as it appears that the most stringent 
peptide FDR threshold does not yield the most accurate median protein abundance ratios, 
at least for the UPS1 proteins present in this dataset.  In fact the “best” results (in terms of 
the accuracy of median protein abundance ratios and minimal spread of the data) were 
found when a threshold of 1% peptide FDR was applied, giving median values of 28.81, 10.74 
and 3.97 compared to the expected ratios of 27, 9 and 3 respectively.  Generally, the E/C and 
E/D ratios are overestimated while the E/B ratio is underestimated (the two exceptions are 
the E/B ratio at 1% FDR that is overestimated and the E/C ratio at 20% FDR that is slightly 
underestimated).  The suppression of the ratios at higher peptide FDR thresholds may be 
explained by the inclusion of lower abundance peptides in the estimation of protein 
abundance – either low abundance peptides which are incorrectly assigned to that protein, 
or which are correctly assigned but which are not fully ionised and/or detected within the 
mass spectrometer.
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Figure 30: Box plots showing abundance ratios for all comparisons analysed using multiple peptide FDR thresholds with Mascot data in Progenesis LC-MS.
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Mascot Data only - UPS1 protein abundance ratios 
  0.0FDR 1.0FDR 5.0FDR 10.0FDR 20.0FDR 
  median 
IQ 
range median 
IQ 
range median 
IQ 
range median 
IQ 
range median 
IQ 
range 
EvB 26.11 25.3 28.81 17.16 23.43 15.99 20.89 18.38 17.91 17.11 
EvC 11.53 5.51 10.74 2.96 9.63 3.11 9.43 3.34 8.92 3.91 
EvD 3.91 0.92 3.97 0.78 3.84 0.65 3.81 0.68 3.73 0.82 
Table 10: Table of median and interquartile-range values for all ratio comparisons at 0.0, 1.0, 5.0, 10.0 and 20.0% 
peptide FDR thresholds. 
 
The trade off in terms of the number of identified UPS1 proteins was also considered (see 
Table 11, middle column), and it was seen that the highest proportion of the UPS1 proteins 
present was identified at the highest peptide FDR threshold.  This is as would be expected, 
and in fact all of the UPS1 proteins were identified at both the 10 and 20% peptide FDR 
thresholds.  However only 45 and 46 proteins were identified respectively when a threshold 
requiring two or more peptides used for quantitation of the protein was applied.  At 1% 
peptide FDR 44 of the UPS1 proteins were identified, with 41 proteins passing the two 
peptide threshold, giving sensitivity values of 0.92 and 0.85 respectively.  It is considered that 
this is a reasonable trade off.  The total number of yeast proteins reported was also studied 
(see Table 11, right hand column), and the expected correspondence of increased peptide 
FDR threshold with an increased number of identified proteins was observed (however it was 
observed that a high peptide threshold is required to remove unreliable data as hundreds of 
concatenated target-decoy proteins are reported in the result sheet, and setting different 
protein probability thresholds has very little affect in terms of reducing the number of decoy 
identifications, therefore it should be noted that using these thresholds there are unsuitably 
high numbers of false positives for use in biological study). 
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FDR threshold (%) 
no. of UPS1 proteins (no. passing 2 
quant peptide threshold) 
no. of yeast proteins (no. passing 2 
quant peptide threshold) 
0 33 (22) 702 (386) 
1 44 (41) 1308 (747) 
5 47 (45) 2418 (1126) 
10 48 (45) 2686 (1826) 
20 48 (46) 2735 (2432) 
Table 11: Table showing the number of UPS1 and yeast proteins identified at all FDR thresholds 
 
4.3.2 - Peptide FDR thresholds applied within Scaffold using Mascot, OMSSA 
and X!Tandem search sesults 
 
On considering the results following multiple search engine analysis and post processing with 
Scaffold using a 5.0% protein probability and 0.1, 0.5, 1.0, 2.0 and 5.0% peptide FDR 
thresholds, it is seen that all 48 UPS1 proteins are identified at all peptide FDR thresholds, 
with 46 proteins passing the two peptide threshold (see Figure 31 and Table 12). 
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Figure 31: Box plots showing abundance ratios for all comparisons analysed using multiple peptide FDR thresholds 
in Scaffold with Mascot, OMSSA and X!Tandem data in Progenesis LC-MS 
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Scaffold Data at 5% Protein Probability - peptide FDR thresholds 
            
  0.1%FDR 0.5%FDR 1.0%FDR 2.0%FDR 5.0%FDR 
EvB 16.75 16.75 16.1 16.1 16.1 
EvC 8.95 8.95 8.28 8.24 8.22 
EvD 3.75 3.75 3.74 3.73 3.73 
Table 12: Table showing median values for all ratio comparisons between conditions (EvB, EvC and EvD) at 5% 
protein probability and 0.1, 0.5, 1.0, 2.0 and 5.0% peptide FDR thresholds. 
 
Once a stringent peptide FDR threshold is applied (1% peptide FDR, see Table 13) the median 
ratios reported are far closer to the ground truth (27, 9 and 3 respectively for the EvB, EvC 
and EvD comparisons), with the results from setting both 1, 2 and 5% protein FDR giving 
median ratios of 29.43, 10.40 and 4.03.  Even at 10% protein FDR the ratios are still close to 
the ground truth for the EvC and EvD comparisons (9.4 and 3.93), but the ratio reported for 
the EvB comparison is depressed (10.27).  At high protein FDR (1 and 2%) a very small number 
of decoy hits was observed (4 decoy hits), with only a slight increase in the number of decoy 
hits at 5% protein FDR (27 decoy hits).  The number of decoy hits then increased to over 100 
when a 10% protein FDR threshold was used. 
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Figure 32:  Box plot showing abundance ratios for all ratio comparisons analysed using 1% peptide FDR and 1% 
protein FDR thresholds in Scaffold with Mascot, OMSSA and X!Tandem data and post processed in Progenesis LC-
MS 
 
 
 
 
 
 
 
 
Table 13: Table showing median and inter-quartile range values for all ratio comparisons between conditions 
(EvB, EvC and EvD) at 1% peptide FDR with 1, 2, 5 and 10% protein FDR thresholds. 
 
Scaffold Data - UPS1 protein abundance ratios     
 1.0%FDR  2.0%FDR  5.0%FDR  10.0%FDR  
 median IQ 
range 
median IQ 
range 
median IQ 
range 
median IQ 
range 
EvB 29.43 18.79 29.43 18.79 29.43 19.19 19.27 16.95 
EvC 10.4 2.97 10.4 2.97 10.4 2.93 9.4 3.08 
EvD 4.03 0.61 4.03 0.61 4.03 0.59 3.93 0.57 
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4.4 - Discussion and Conclusions 
 
This was a very brief study due to time constraints, however the results from the Mascot 
analysis demonstrate that the relationship between the reliable identification of proteins 
and their reliable quantitation is extremely non-trivial and that further study in this area 
would be beneficial to the field.  For this data at least, the suggestion is that a 1% peptide 
FDR threshold (applied to the data when ordered by the reported Mascot score) is most 
beneficial in terms of obtaining accurate protein abundance ratios.  It would be useful to 
repeat the analysis using a sample where a greater proportion of the proteins present were 
of known abundance, or possibly with a simple sample containing only a small number of 
proteins. 
 
The analysis using Scaffold illustrated the importance of selecting the correct thresholds, 
with a seemingly sensible strategy giving highly erroneous results in terms of the median 
ratio values reported.  Using a low protein probability threshold gives rise to high FDR and 
many decoy identifications, and altering the peptide FDR has little effect in terms of reducing 
the FDR.  It is observed that the most sensible strategy appears to be the use of a 1% peptide 
FDR threshold and a protein FDR threshold of 1-5%, as this gives median ratios closest to the 
ground truth for this dataset, and with very low numbers of decoy hits. 
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5– Discussion 
 
5.1 – Project Overview 
 
5.1.1 – Achievements 
The scope of this project was to consider the methods of analysis that are available to 
researchers in the field of quantitative label-free proteomics and possible methods to 
increase the confidence of experimental results through the parallel use of multiple post 
processing software pipelines.  To this end comparisons were made between popular 
software pipelines, between mass spectrometry instruments, and between different 
identification thresholds.  Out of these comparisons arose suggestions of methods that can 
be used to increase the confidence in both the identification of proteins and the differential 
expression of those proteins between different experimental conditions. 
 
5.1.2 – Key points highlighted by this project 
 
5.1.2.1 - There is a great need for representative standard datasets where the ground truth 
is known, and for these datasets to be made available to the bioinformatics community via 
data repositories, so as to allow an increase in the number of benchmarking studies looking 
at methods to increase to confidence and reliability of data obtained from various software 
pipelines and experimental or post processing methods.  In particular, there is a need to 
ensure that the “background proteins” in standard samples where a spike in has been applied 
for comparison are truly homologous across all replicates of the sample, as variation in this 
background causes uncertainty in the assignment of differential expression profiles (ie 
assignment of differential expression for “background proteins” cannot be inferred as a false 
positive when there are genuine changes in their abundance between samples). 
5.1.2.2 - Global normalisation methods do not appear to be suitable for the analysis of 
datasets where there is more than one distribution in the data, for example when both host 
and parasite cells are present, or when proteins are spiked into a background sample.  The 
skewing of differential expression ratios resulting from the application of global 
normalisation to datasets containing multiple distributions becomes an important 
consideration for those scientists studying such host-parasite or similar systems, and a 
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possible method to manage this is suggested within this thesis – namely to apply 
normalisation to each set of proteins individually (ie to host proteins and parasite proteins) 
– and this has been used successfully by colleagues on real data. 
5.1.2.3 - While statistical post-processing, for example using the QPROT tool, can be very 
successful in terms of improved sensitivity and reduced FDR, the choice of identification 
threshold prior to quantitative analysis can also have a great impact on the sensitivity and 
FDR of the quantitative results.  Therefore if possible these input thresholds should be 
optimised for the dataset in question, and from the studies presented in this thesis an input 
threshold of 1% peptide level FDR appears to be the most effective in terms of outputting 
the correct ratios between conditions and maintaining sensitivity without reducing the 
number of identified proteins past what is acceptable. 
5.1.2.4 - The parallel analysis of a single biological sample on different instrument platforms 
yields intensity values that are well correlated at the protein level, with slightly lower 
correlation at the feature level, and this correlation is improved (at least for the dataset 
studied) by using hi3 data as opposed to using total abundance data.   This may be due to a 
combination of the most abundant peptides being most likely to be present at the same 
abundance as the parent protein, and the possibility of low abundance peptides skewing or 
confusing the assigned abundance of the parent protein.  Also, while the application of 
quartile thresholds by abundance is efficacious in improving the correlation between 
instruments (particularly at the feature level as the effect is somewhat masked at the protein 
level), the effect of score thresholds is less predictable, with an increased score threshold 
actually reducing the correlation at the feature level in some cases.  Presumably this is due 
to the application of thresholds above an (unknown) optimum point removing true positives 
from the result list. 
 
5.1.3 – Limitations 
The intention throughout this project was to use standard procedures for all software 
packages, and therefore it is possible that the results obtained could be improved if the 
methods used were further optimised for the data being considered.  However, the use of 
standard procedures was considered more representative of the situation in which a lab 
scientist is working with experimental data where the ground truth is unknown and therefore 
the opportunity for optimisation is highly limited. 
In the assessment of correlation between instruments there are some differences in the 
standard chromatographic conditions for two instruments, and in addition it was necessary 
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to perform initial analysis and protein inference for the two datasets in separate software 
environments due to vendor software being necessary to analyse the MSE data type.  
Therefore it is not possible to exclude these differences as a potential cause of the variation 
observed between the data output from the two instruments. 
 
5.1.4 - Suggestions for future work 
For both the software and instrument comparison studies it would be beneficial to repeat 
the studies with a dataset that has a robust background that is truly homologous across all 
conditions, and which contains multiple spike-ins or protein populations of known 
abundance and/or at known ratios between conditions. 
For the instrument study it would also be useful to repeat the study using two or more 
instruments that produce data formats that allow truly parallel post-processing, and using 
identical chromatographic parameters.  It would also be useful to perform the analysis using 
different samples to ensure that the conclusions drawn are not specific to the single 
biological system studied. 
 
5.2 – Relevance to the field 
While there are some limitations in the results presented here, important considerations are 
raised in relation to data normalisation and threshold selection.  Suggestions are made for 
the use of a simple spectral counting technique (such as emPAI) in tandem with an intensity 
based technique and additional statistical post-processing to improve sensitivity and reduce 
FDR in quantitative results.  There is also confirmation for the core assumption that 
abundance data obtained from different instrument platforms is broadly correlated is 
correct, at least for the instruments used and for the dataset studied as part of this thesis.  
The work presented here also clearly demonstrates the need for freely available and truly 
representative standard datasets, as it is necessary for there to be confidence in the ground 
truth of the dataset to allow reliable conclusions to be made regarding the effect on 
sensitivity and FDR when using different thresholds and post processing methods.  
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